<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2024.1404884</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Potential roles of voltage-gated ion channel disruption in Tuberous Sclerosis Complex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Egido-Betancourt</surname> <given-names>Hailey X.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2809977/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Strowd III</surname> <given-names>Roy E.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Raab-Graham</surname> <given-names>Kimberly F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/423917/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Translational Neuroscience, Wake Forest University School of Medicine</institution>, <addr-line>Winston-Salem, NC</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurology, Wake Forest University School of Medicine</institution>, <addr-line>Winston-Salem, NC</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Nobuyuki Takei, Niigata University, Japan</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Jianxiang Liao, Shenzhen Children&#x2019;s Hospital, China</p><p>Toshiyuki Kobayashi, Juntendo University, Japan</p></fn>
<corresp id="c001">&#x002A;Correspondence: Kimberly F. Raab-Graham, <email>kraabgra@wakehealth.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>17</volume>
<elocation-id>1404884</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>06</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Egido-Betancourt, Strowd and Raab-Graham.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Egido-Betancourt, Strowd and Raab-Graham</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Tuberous Sclerosis Complex (TSC) is a lynchpin disorder, as it results in overactive mammalian target of rapamycin (mTOR) signaling, which has been implicated in a multitude of disease states. TSC is an autosomal dominant disease where 90% of affected individuals develop epilepsy. Epilepsy results from aberrant neuronal excitability that leads to recurring seizures. Under neurotypical conditions, the coordinated activity of voltage-gated ion channels keep neurons operating in an optimal range, thus providing network stability. Interestingly, loss or gain of function mutations in voltage-gated potassium, sodium, or calcium channels leads to altered excitability and seizures. To date, little is known about voltage-gated ion channel expression and function in TSC. However, data is beginning to emerge on how mTOR signaling regulates voltage-gated ion channel expression in neurons. Herein, we provide a comprehensive review of the literature describing common seizure types in patients with TSC, and suggest possible parallels between acquired epilepsies with known voltage-gated ion channel dysfunction. Furthermore, we discuss possible links toward mTOR regulation of voltage-gated ion channels expression and channel kinetics and the underlying epileptic manifestations in patients with TSC.</p>
</abstract>
<kwd-group>
<kwd>ion channels</kwd>
<kwd>potassium</kwd>
<kwd>calcium</kwd>
<kwd>sodium</kwd>
<kwd>tuberous sclerosis complex</kwd>
<kwd>epilepsy</kwd>
</kwd-group>
<contract-num rid="cn001">NS105005</contract-num>
<contract-num rid="cn001">NS105005-03S1</contract-num>
<contract-num rid="cn002">AA029691</contract-num>
<contract-num rid="cn002">T32AA007565</contract-num>
<contract-num rid="cn003">W81XWH-14-1-0061</contract-num>
<contract-num rid="cn003">W81XWH-19-1-0202</contract-num>
<contract-num rid="cn004">T32DA041349</contract-num>
<contract-sponsor id="cn001">National Institute of Neurological Disorders and Stroke<named-content content-type="fundref-id">10.13039/100000065</named-content></contract-sponsor>
<contract-sponsor id="cn002">National Institute on Alcohol Abuse and Alcoholism<named-content content-type="fundref-id">10.13039/100000027</named-content></contract-sponsor>
<contract-sponsor id="cn003">Medical Research and Materiel Command<named-content content-type="fundref-id">10.13039/100000182</named-content></contract-sponsor>
<contract-sponsor id="cn004">National Institute on Drug Abuse<named-content content-type="fundref-id">10.13039/100000026</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="112"/>
<page-count count="11"/>
<word-count count="9213"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Disease Mechanisms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Tuberous sclerosis complex (TSC) is an autosomal dominant disease affecting roughly 1 in 6000 live births, with an estimated prevalence of 1 in 14,000 to 1 in 25,000 (<xref ref-type="bibr" rid="B24">Curatolo and Moavero, 2012</xref>; <xref ref-type="bibr" rid="B50">Kothare Sanjeev et al., 2014</xref>). Disease causing mutations in either the <italic>TSC1</italic> or <italic>TSC2</italic> gene lead to loss of protein function (<xref ref-type="bibr" rid="B67">O&#x2019;Callaghan et al., 2004</xref>; <xref ref-type="bibr" rid="B25">Curatolo et al., 2008</xref>). TSC1 and TSC2 form dimers to inhibit the activity of mammalian target of rapamycin (mTOR), composed of two complexes mTORC1 and mTORC2. Loss of either TSC1 or TSC2 leads to hyperactive mTOR signaling and tuberous malformations. More than 90% of affected individuals experience seizures over the course of their lifetime (<xref ref-type="bibr" rid="B67">O&#x2019;Callaghan et al., 2004</xref>; <xref ref-type="bibr" rid="B48">Kelleher and Bear, 2008</xref>; <xref ref-type="bibr" rid="B88">Stafstrom et al., 2017</xref>). As the etiology as TSC is well established, mechanism based treatments such as the mTORC1 inhibitor, rapamycin and other &#x201C;rapalogues&#x201D;, has been the focus of several clinical trials to treat TSC-related seizures (<xref ref-type="bibr" rid="B38">Franz et al., 2018</xref>).</p>
<p>TSC patients suffer from both focal and generalized epilepsy syndromes including febrile seizures, infantile spasms, focal seizures, and absence seizures (<xref ref-type="bibr" rid="B50">Kothare Sanjeev et al., 2014</xref>). Seizures may arise in TSC in two possible ways. Some studies speculate that seizure activity is generated by brain malformations that result from cortical tubers, which are composed of dysmorphic neurons and gliotic cells and are commonly seen in TSC patients (<xref ref-type="bibr" rid="B88">Stafstrom et al., 2017</xref>; <xref ref-type="bibr" rid="B112">Zou et al., 2017</xref>). The tubers may be surgically removed to provide temporary relief from the seizures (<xref ref-type="bibr" rid="B10">Bollo et al., 2008</xref>). Second, some studies suggest that hyperactive mTOR signaling itself can disrupt the excitatory/inhibitory (E/I) balance among neuronal networks (<xref ref-type="bibr" rid="B5">Bateup et al., 2013</xref>). Thus, in the absence of tubers, TSC patients may be susceptible to seizure-like activity and downstream neuronal damage due to hyperactive mTORC1 signaling, further disrupting mRNA translation and protein expression (<xref ref-type="bibr" rid="B5">Bateup et al., 2013</xref>). Cortical tuber development has been widely studied in TSC [previously reviewed in <xref ref-type="bibr" rid="B98">Wong (2008)</xref> and <xref ref-type="bibr" rid="B57">Lu et al. (2018)</xref>]; however, little is known regarding the molecular underpinnings of hyperexcitable networks downstream of mTOR signaling, that underlie epilepsy in TSC, in the absence of cortical tubers.</p>
<p>For decades, dysregulation of ion channels, such as voltage-gated potassium, calcium, and sodium channels, has been suggested to be the leading cause of shifts in neuronal excitability, that underlie epilepsy (<xref ref-type="bibr" rid="B71">Poolos and Johnston, 2012</xref>). Recently, evidence linking mTOR signaling to ion channel expression in neurons has emerged [reviewed further in <xref ref-type="bibr" rid="B73">Raab-Graham and Niere (2017)</xref>]. Together, these findings have led us to ask the question of whether voltage-gated ion channels are contributing to TSC-related seizures. Herein, we discuss known voltage-gated ion channels currently associated with acquired epilepsies, but not yet understood in the context of TSC. The goal of this review will be to extrapolate and expand on the current findings of voltage-gated channels implicated in other epilepsies, where aberrant mTOR signaling occurs, while surmising their role in TSC-related seizures.</p>
</sec>
<sec id="S2">
<title>mTOR as a putative voltage sensor</title>
<p>As mentioned above, loss of function mutations in the <italic>TSC1</italic> or <italic>TSC2</italic> genes results in hyperactive mTOR signaling (<xref ref-type="bibr" rid="B25">Curatolo et al., 2008</xref>; <xref ref-type="bibr" rid="B20">Cho, 2011</xref>; <xref ref-type="bibr" rid="B99">Wong, 2013</xref>; <xref ref-type="bibr" rid="B88">Stafstrom et al., 2017</xref>). mTOR consist of two protein complexes, mTORC1 and mTORC2. Herein, we will focus on mTORC1 signaling as it is a serine/threonine kinase that regulates mRNA translation (<xref ref-type="bibr" rid="B25">Curatolo et al., 2008</xref>; <xref ref-type="bibr" rid="B24">Curatolo and Moavero, 2012</xref>; <xref ref-type="bibr" rid="B26">Curatolo et al., 2015</xref>; <xref ref-type="bibr" rid="B78">Roach, 2016</xref>; <xref ref-type="bibr" rid="B73">Raab-Graham and Niere, 2017</xref>), which may alter the expression of epilepsy associated ion channels in neurons (<xref ref-type="fig" rid="F1">Figure 1</xref>). mTORC1&#x2019;s downstream signaling is required for many forms of synaptic plasticity, synapse formation, and recently ? Site specific expression of ion channels in neuronal dendrites (<xref ref-type="bibr" rid="B74">Raab-Graham et al., 2006</xref>; <xref ref-type="bibr" rid="B20">Cho, 2011</xref>; <xref ref-type="bibr" rid="B12">Brewster et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Meng et al., 2013</xref>; <xref ref-type="bibr" rid="B99">Wong, 2013</xref>). Thus, an emerging theory is that mTORC1 activity may serve as a &#x201C;voltage-sensor&#x201D; turning on and off to maintain the membrane potential in an optimal range, through protein synthesis and repression of ion channel mRNAs (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). Thus, if mTOR activity is constitutive, as in the case of TSC, ion channel expression/repression that promotes neuronal excitability will go unchecked (<xref ref-type="bibr" rid="B53">Lasarge and Danzer, 2014</xref>). Epilepsy has been classically considered a disorder of ion channel dysfunction (<xref ref-type="bibr" rid="B71">Poolos and Johnston, 2012</xref>). Together, these data may explain why independent studies suggest that overactive mTOR signaling itself can lead to epilepsy (<xref ref-type="bibr" rid="B108">Zeng et al., 2008</xref>; <xref ref-type="bibr" rid="B26">Curatolo et al., 2015</xref>; <xref ref-type="bibr" rid="B85">Sosanya et al., 2015</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). To date, the literature is sparse in its consolidation of excessive mTOR signaling and ion channel dysfunction in TSC-related epilepsies.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>mTORC1 signaling leads to changes in ion channel expression. Schematic of canonical mTOR signaling pathway <bold>(middle)</bold>. mTORC1 signaling pathway represses the mRNA translation of potassium channels such that mTORC1 inhibition with the drug rapamycin increases the expression of K<sub>v</sub>1.1, K<sub>v</sub>1.2, and K<sub>v</sub>&#x03B2;2 <bold>(right)</bold> (<xref ref-type="bibr" rid="B86">Sosanya et al., 2013</xref>, <xref ref-type="bibr" rid="B85">2015</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). Interestingly, mTOR hyperactivity differentially alters calcium influx via Ca<sub>v</sub>1.2, &#x03B1;2&#x03B4;2, and Ca<sub>v</sub>1.3 channel expression (<xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref>; <xref ref-type="bibr" rid="B66">Niere et al., 2023</xref>). mTOR hyperactivity leads to augmented calcium influx in the soma via an increase in Ca<sub>v</sub>1.3 gene and protein expression and slight increase of Ca<sub>v</sub>1.2 (<xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref>) <bold>(right)</bold>. On the other hand, RNA binding protein DJ1 binds the mRNA coding for Ca<sub>v</sub>1.2 and &#x03B1;2&#x03B4;2 and represses translation. This repression causes deficits in L-VGCC dendritic signaling (<xref ref-type="bibr" rid="B66">Niere et al., 2023</xref>). Notably, with seizure induction, blocking early-stage epileptogenesis in a model of temporal lobe epilepsy with rapamycin increases the expression of K<sub>v</sub>1.1 <bold>(left)</bold>. A secondary mechanism of repression kicks in to repress K<sub>v</sub>1.1 expression with extended use of rapamycin (<xref ref-type="bibr" rid="B85">Sosanya et al., 2015</xref>) while continued use of rapamycin restores K<sub>v</sub>1.4 and K<sub>v</sub>4.2 (<xref ref-type="bibr" rid="B12">Brewster et al., 2013</xref>) during late stage epileptogenesis. Dynamic expression of RNA-binding proteins and microRNAs regulate the expression of K<sub>v</sub>1.1. HuD increases the translation of K<sub>v</sub>1.1 when mTORC1 is turned off and miR-129 represses the translation of K<sub>v</sub>1.1 when mTORC1 is turned on. For further mechanistic detail, please see the following articles: (<xref ref-type="bibr" rid="B86">Sosanya et al., 2013</xref>, <xref ref-type="bibr" rid="B85">2015</xref>). Interestingly, miR-129 expression increases with extended use of rapamycin, likely drives the second wave of K<sub>v</sub>1.1 repression and an increases in seizure frequency (<xref ref-type="bibr" rid="B85">Sosanya et al., 2015</xref>). Dotted lines reflect multiple molecular steps between proteins. Created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender.com</ext-link>. Agreement number: <italic>VB26LQZB9H.</italic></p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-17-1404884-g001.tif"/>
</fig>
</sec>
<sec id="S3">
<title>Types of TSC-associated seizures</title>
<p>The most common type of seizure in children with TSC are infantile spasms, occurring between 3 and 9 months after birth (<xref ref-type="bibr" rid="B70">Pellock et al., 2010</xref>; <xref ref-type="bibr" rid="B3">Appleton, 2011</xref>; <xref ref-type="bibr" rid="B77">Randle, 2017</xref>). Many different semiologies can be observed such as eye deviation as well as sudden bilateral and symmetrical tonic contractions, which last a few seconds (<xref ref-type="bibr" rid="B28">Curatolo et al., 2001</xref>). It has long been hypothesized that if these seizures are left untreated, children suffering from infantile spasms will experience impairment in developmental progress and more severe neurologic problems, such as autism spectrum disorder (<xref ref-type="bibr" rid="B70">Pellock et al., 2010</xref>, <xref ref-type="bibr" rid="B1">Alliance, 2020</xref>). Interestingly, several clinical trials have since discovered contrary findings with respect to targeting early life infantile spasms in TSC patients. One such trial found that preventative treatment with vigabatrin, the first line of treatment for infantile spasms which targets gamma-amino butyric acid (GABA)-transaminase, ultimately increases the concentration of GABA present in the brain (<xref ref-type="bibr" rid="B104">Yum et al., 2013</xref>). However, treatment did not delay or lower the incidence of other seizure types, such as focal and drug resistant epilepsy nor improve neurocognitive outcome at 24 months of age in TSC children (<xref ref-type="bibr" rid="B6">Bebin et al., 2024</xref>). On the other hand, TSC patients who showed signs of epileptiform activity before seizure onset, and were treated with vigabatrin, took longer to display clinical seizure and the preventative treatment reduced the risk of other clinical seizures (<xref ref-type="bibr" rid="B51">Kotulska et al., 2021</xref>); however, neurocognition was not determined. Further research targeting the underlying mechanisms of infantile spasms.</p>
<p>The second most common seizure type is focal onset seizures, previously called focal or partial seizures, as they originate at some specific point in the brain. These seizures differ from infantile spasms in that they can be either awareness or impaired awareness with non-motor onset or motor onset (<xref ref-type="bibr" rid="B2">Almobarak et al., 2018</xref>). These seizures can precede or coexist with infantile spasms, or even evolve from infantile spasms (<xref ref-type="bibr" rid="B104">Yum et al., 2013</xref>). While the cause of focal seizures is not fully understood, some suggest that focal insults are caused by brain malformations resulting from structural tuber alterations (<xref ref-type="bibr" rid="B87">Stafstrom and Carmant, 2015</xref>; <xref ref-type="bibr" rid="B27">Curatolo et al., 2018</xref>). To mimic focal seizures in a mouse model of TSC, pups <italic>in utero</italic> underwent electroporation to focally express constitutively active Rheb (Rheb<italic><sup>CA</sup></italic>), to augment mTOR activity only in the selected area. Indeed, this model is similar to a model of cortical dysplasia that experiences focal seizures as a result of expressing Rheb<italic><sup>CA</sup></italic> (<xref ref-type="bibr" rid="B43">Hsieh et al., 2016</xref>). The authors found that varying the concentration of Rheb led to high levels of mTOR activity, which increased seizure frequency and correlated with the degree of disease severity (<xref ref-type="bibr" rid="B64">Nguyen et al., 2019</xref>). These findings further the notion that focal seizures, in the absence of tuber abnormalities, is thought to be caused by select mTOR-afflicted neurons, and results in altered network excitability and seizures.</p>
<p>TSC patients may also suffer from generalized onset, formerly known to encompass tonic seizures, myoclonic seizures, and absence seizures (<xref ref-type="bibr" rid="B3">Appleton, 2011</xref>; <xref ref-type="bibr" rid="B49">Kiriakopoulos and Osborne, 2017</xref>). These seizures can begin focally and bilaterally expand to larger aspects of the cortex, although not necessarily the entire cortex. Patients with generalized onset seizures present with stiffened muscles, rhythmical jerking, and impaired awareness (<xref ref-type="bibr" rid="B87">Stafstrom and Carmant, 2015</xref>, <xref ref-type="bibr" rid="B2">Almobarak et al., 2018</xref>).</p>
<p>There is a substantial portion of TSC patients that continue to have seizures despite maximum aggressive anti-seizure treatment. For these patients, new approaches to management are needed. For example, if focal seizures coexist or precede infantile spasms, vigabatrin treatment can be less effective or have no effect. This is thought to be due to the medication only targeting one seizure type (<xref ref-type="bibr" rid="B104">Yum et al., 2013</xref>). Thus, it is imperative to determine the &#x201C;molecular origin&#x201D; of seizure onset, in order to better determine the course of treatment for a TSC affected individual.</p>
</sec>
<sec id="S4">
<title>Clues from transcriptome studies of TSC, mTOR-mediated ion channel Expression, and speculated epilepsy</title>
<p>A few studies have examined the transcriptome of human cortical tubers removed from patients with TSC (<xref ref-type="bibr" rid="B9">Boer et al., 2010</xref>; <xref ref-type="bibr" rid="B62">Mills et al., 2017</xref>). <xref ref-type="table" rid="T1">Table 1</xref> lists transcripts associated with voltage-gated channel expression (<xref ref-type="bibr" rid="B40">Heinemann et al., 1996</xref>; <xref ref-type="bibr" rid="B34">Escayg et al., 1998</xref>; <xref ref-type="bibr" rid="B33">Ebert et al., 2008</xref>; <xref ref-type="bibr" rid="B111">Zhang et al., 2015</xref>). Interestingly, all the genes listed code for auxiliary subunits that serve to increase the surface expression of the pore-forming subunit or change the ion channel kinetics. These data further convey the need to investigate the expression and function of the pore forming subunits in neuronal models of TSC. While mRNA does not necessarily mean changes in protein expression, others have demonstrated that mTOR is overactive in other models of epilepsy, similar to TSC, and these genes that code for these mTOR-dependent ion channels are summarized in <xref ref-type="table" rid="T2">Table 2</xref> (<xref ref-type="bibr" rid="B92">Wang et al., 1993</xref>; <xref ref-type="bibr" rid="B59">McCormack et al., 1995</xref>; <xref ref-type="bibr" rid="B14">Burkhalter et al., 2006</xref>; <xref ref-type="bibr" rid="B44">Imbrici et al., 2007</xref>; <xref ref-type="bibr" rid="B21">Christel et al., 2012</xref>; <xref ref-type="bibr" rid="B54">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="B101">Xie et al., 2014</xref>; <xref ref-type="bibr" rid="B91">Villa and Combi, 2016</xref>; <xref ref-type="bibr" rid="B72">Punetha et al., 2019</xref>; <xref ref-type="bibr" rid="B30">Dahimene et al., 2022</xref>). Finally, in <xref ref-type="table" rid="T3">Table 3</xref>, we propose a list of putative voltage-gated ion channels that may be dysregulated in TSC (<xref ref-type="bibr" rid="B81">Ser&#x00F4;dio and Rudy, 1998</xref>; <xref ref-type="bibr" rid="B95">Wappl et al., 2002</xref>; <xref ref-type="bibr" rid="B46">Jarnot and Corbett, 2006</xref>; <xref ref-type="bibr" rid="B68">Ogiwara et al., 2007</xref>, <xref ref-type="bibr" rid="B69">2018</xref>; <xref ref-type="bibr" rid="B35">Estacion et al., 2010</xref>; <xref ref-type="bibr" rid="B84">Smets et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B100">Wormuth et al., 2016</xref>; <xref ref-type="bibr" rid="B36">Fan et al., 2017</xref>; <xref ref-type="bibr" rid="B110">Zhang et al., 2020</xref>). Although, currently, there is no direct evidence of the potential role of dysfunction in the following voltage-gated ion channels leading to the hyperexcitable pathology in TSC, we speculate that these channels may play a role in the different seizure types present in TSC patients throughout their lives.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Determined TSC ion channel transcripts associated with epilepsy.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Gene name</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Channel type</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Localization</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Seizure classification</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Function</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Direction noted</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic>KCNAB1</italic></td>
<td valign="top" align="center">K<sub>v</sub>&#x03B2;1</td>
<td valign="top" align="center">Brain</td>
<td valign="top" align="center">Early-onset epilepsy</td>
<td valign="top" align="center">Inactivation regulator of alpha potassium channels</td>
<td valign="top" align="center">Increase</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B40">Heinemann et al., 1996</xref>; <xref ref-type="bibr" rid="B111">Zhang et al., 2015</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNB2</italic></td>
<td valign="top" align="center">Ca<sub>v</sub>&#x03B2;2</td>
<td valign="top" align="center">Cardiac, skeletal, smooth, and brain</td>
<td valign="top" align="center">Epilepsy</td>
<td valign="top" align="center">Modulation the gating of alpha calcium channels</td>
<td valign="top" align="center">Increase</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B33">Ebert et al., 2008</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNB4</italic></td>
<td valign="top" align="center">Ca<sub>v</sub>&#x03B2;4</td>
<td valign="top" align="center">Brain</td>
<td valign="top" align="center">Absence epilepsy; idiopathic generalized epilepsy; juvenile myoclonic epilepsy</td>
<td valign="top" align="center">Modulation the gating of alpha calcium channels</td>
<td valign="top" align="center">Increase</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B13">Burgess et al., 1997</xref>; <xref ref-type="bibr" rid="B34">Escayg et al., 1998</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>This table represents determined TSC ion channel transcripts from <xref ref-type="bibr" rid="B9">Boer et al. (2010)</xref> (fold change reported) and epilepsy associated genes (<xref ref-type="bibr" rid="B93">Wang et al., 2017</xref>) (no fold change reported).</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>mTOR dependent voltage-gated ion channels associated with seizures.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Gene name</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Channel type</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Localization</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Seizure classification</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Function</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Observed expression</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Effect on neuronal activity</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic>KCNA1</italic></td>
<td valign="top" align="left">K<sub>v</sub>1.1</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Epilepsy; generalized or partial</td>
<td valign="top" align="left">Initiation and propagation, shaping, regulating action potential</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B92">Wang et al., 1993</xref>; <xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>; <xref ref-type="bibr" rid="B91">Villa and Combi, 2016</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>KCNA2</italic></td>
<td valign="top" align="left">K<sub>v</sub>1.2</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Myoclonic epilepsy</td>
<td valign="top" align="left">Initiation and propagation, shaping, regulating action potential; Inactivation regulator of alpha potassium channels</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B92">Wang et al., 1993</xref>; <xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>; <xref ref-type="bibr" rid="B91">Villa and Combi, 2016</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>KCNA4</italic></td>
<td valign="top" align="left">K<sub>v</sub>1.4</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Episodic Ataxia; Epilepsy</td>
<td valign="top" align="left">Regulates presynaptic neurotransmitter release; regulates intrinsic excitability</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B44">Imbrici et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Brewster et al., 2013</xref>; <xref ref-type="bibr" rid="B101">Xie et al., 2014</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>KCND2</italic></td>
<td valign="top" align="left">K<sub>v</sub>4.2</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Infant-onset Epilepsy</td>
<td valign="top" align="left">Determine the extent of inactivation for the cell</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B14">Burkhalter et al., 2006</xref>; <xref ref-type="bibr" rid="B54">Lee et al., 2014</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>KCNAB2</italic></td>
<td valign="top" align="left">K<sub>v</sub>&#x03B2;2</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Epilepsy</td>
<td valign="top" align="left">Inactivation regulator of alpha potassium channels</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B59">McCormack et al., 1995</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1C</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>1.2</td>
<td valign="top" align="left">Cardiac, smooth muscle, neuronal, adrenal, chromaffin cells</td>
<td valign="top" align="left">Febrile seizures</td>
<td valign="top" align="left">Regulates cardiac action potential; excitation-coupling</td>
<td valign="top" align="left">Increase (somatic); Decrease (dendritic)</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B21">Christel et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref>; <xref ref-type="bibr" rid="B66">Niere et al., 2023</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1D</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>1.3</td>
<td valign="top" align="left">Endocrine, neuronal, adrenal, chromaffin cells</td>
<td valign="top" align="left">Epilepsy-Associated</td>
<td valign="top" align="left">Sinoatrial pacemaking</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B21">Christel et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA2D1</italic></td>
<td valign="top" align="left">&#x03B1;2&#x03B4;1</td>
<td valign="top" align="left">Skeletal muscle, brain</td>
<td valign="top" align="left">Epilepsy, cerebellar ataxia</td>
<td valign="top" align="left">Regulates VGCC current density, and activation/<break/> inactivation kinetics</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B66">Niere et al., 2023</xref>; human protein atlas; <xref ref-type="bibr" rid="B30">Dahimene et al., 2022</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA2D2</italic></td>
<td valign="top" align="left">&#x03B1;2&#x03B4;2</td>
<td valign="top" align="left">Lung, brain</td>
<td valign="top" align="left">Epileptic encephalopathy, ataxia</td>
<td valign="top" align="left">Regulates VGCC current density, and activation/<break/> inactivation kinetics</td>
<td valign="top" align="left">Decrease</td>
<td valign="top" align="left">Increase</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B66">Niere et al., 2023</xref>; human protein atlas; <xref ref-type="bibr" rid="B72">Punetha et al., 2019</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>This table represents mTOR modulated voltage-gated ion channels that have a potential role in TSC-associated seizure etiologies. ND, not determined.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T3">
<label>TABLE 3</label>
<caption><p>Voltage-gated ion channels involved in epilepsy-etiologies associated but undetermined in TSC.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Gene Name</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Channel type</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Localization</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Seizure classification</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Function</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Predicted channel function</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic>KCND3</italic></td>
<td valign="top" align="left">K<sub>v</sub>4.3</td>
<td valign="top" align="left">Cardiac muscle, brain</td>
<td valign="top" align="left">Generalized epilepsy</td>
<td valign="top" align="left">Determine the extent of inactivation for the cell</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B81">Ser&#x00F4;dio and Rudy, 1998</xref>; <xref ref-type="bibr" rid="B84">Smets et al., 2015</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1A</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>2.1</td>
<td valign="top" align="left">Neuronal</td>
<td valign="top" align="left">Absence seizures</td>
<td valign="top" align="left">Neurotransmitter release</td>
<td valign="top" align="left">LOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B95">Wappl et al., 2002</xref>, <xref ref-type="bibr" rid="B45">Imbrici et al., 2004</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1E</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>2.3</td>
<td valign="top" align="left">Neuronal</td>
<td valign="top" align="left">Absence epilepsy, human juvenile myoclonic epilepsy</td>
<td valign="top" align="left">Neurotransmitter release</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B100">Wormuth et al., 2016</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1G</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>3.1</td>
<td valign="top" align="left">Neuronal, cardiac</td>
<td valign="top" align="left">Absence seizures</td>
<td valign="top" align="left">Sleep regulation; pacemaking</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B19">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B94">Wang et al., 2016</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>CACNA1H</italic></td>
<td valign="top" align="left">Ca<sub>v</sub>3.2</td>
<td valign="top" align="left">Neuronal, cardiac</td>
<td valign="top" align="left">Absence seizures</td>
<td valign="top" align="left">Regulation of neuronal firing; pacemaking activity</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B19">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B36">Fan et al., 2017</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>SCN1A</italic></td>
<td valign="top" align="left">Na<sub>v</sub>1.1</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Myoclonic epilepsy (Dravet syndrome); generalized epilepsy with generalized clonic seizures</td>
<td valign="top" align="left">Generation and propagation of action potentials</td>
<td valign="top" align="left">LOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B68">Ogiwara et al., 2007</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>SCN2A</italic></td>
<td valign="top" align="left">Na<sub>v</sub>1.2</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Atypical generalized epilepsy; febrile seizures</td>
<td valign="top" align="left">Generation and propagation of action potentials</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B46">Jarnot and Corbett, 2006</xref>; <xref ref-type="bibr" rid="B69">Ogiwara et al., 2018</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>SCN3A</italic></td>
<td valign="top" align="left">Na<sub>v</sub>1.3</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Cryptogenic partial epilepsy-associated;</td>
<td valign="top" align="left">Generation and propagation of action potentials</td>
<td valign="top" align="left">GOF and LOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B35">Estacion et al., 2010</xref>; <xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>SCN8A</italic></td>
<td valign="top" align="left">Na<sub>v</sub>1.6</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Infantile epilepsy</td>
<td valign="top" align="left">Generation and propagation of action potentials</td>
<td valign="top" align="left">GOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref></td>
</tr>
<tr>
<td valign="top" align="left"><italic>SCN9A</italic></td>
<td valign="top" align="left">Na<sub>v</sub>1.7</td>
<td valign="top" align="left">Brain</td>
<td valign="top" align="left">Febrile seizures; afebrile seizures, generalized tonic-clonic seizures, myoclonic or tonic seizures, focal clonic seizures</td>
<td valign="top" align="left">Generation and propagation of action potentials</td>
<td valign="top" align="left">GOF and LOF</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B102">Yang et al., 2018</xref>; <xref ref-type="bibr" rid="B110">Zhang et al., 2020</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>GOF, gain of function; LOF, loss of function.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="S4.SS1">
<title>Voltage-gated potassium channels</title>
<p>Voltage-gated potassium (K<sub><italic>v</italic></sub>) channels represent the largest family of genes in the K<sub><italic>v</italic></sub> channel family that set the resting membrane potential and repolarize action potentials (<xref ref-type="bibr" rid="B22">Cooper, 2012</xref>; <xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>). In general, K<sub><italic>v</italic></sub> channels dampen neuronal activity, so loss of function (LOF) mutations lead to hyperexcitabile circuits and seizures. Potassium channels have different family subtypes that have distinct but similar function. The potassium channel consists of four &#x03B1; subunits and can include four cytoplasmic auxiliary &#x03B2; subunits (<xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>:1). The different configurations of &#x03B1; and &#x03B2; subunits create different properties that dictate their biophysical properties including voltage-sensing and gating properties, described below.</p>
<sec id="S4.SS1.SSS1">
<title>K<sub><italic>v</italic></sub>1</title>
<p><italic>KCNA1</italic> (K<sub><italic>v</italic></sub>1.1) and <italic>KCNA2</italic> (K<sub><italic>v</italic></sub>1.2) have been associated with epilepsy (<xref ref-type="bibr" rid="B22">Cooper, 2012</xref>; <xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>; <xref ref-type="bibr" rid="B11">Boutry-Kryza et al., 2015</xref>). The Kcna family codes for the pore-forming &#x201C;K<sub><italic>v</italic></sub>1&#x201D; subunits, which may compose either A-type or delayed rectifier channels (Raab-graham and Niere, 2017). A-type currents are rapidly activating and fast inactivating, while delayed rectifiers open slowly and remain open (<xref ref-type="bibr" rid="B73">Raab-Graham and Niere, 2017</xref>). Depending on the brain region and cellular composition, the most abundantly expressed &#x03B1; subunits of the K<sub><italic>v</italic></sub>1 subfamily are K<sub><italic>v</italic></sub>1.1, K<sub><italic>v</italic></sub>1.2, and K<sub><italic>v</italic></sub>1.4 (<xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>:1). Interestingly, K<sub><italic>v</italic></sub>1.1 codes for a delayed rectifier, while K<sub><italic>v</italic></sub>1.4 codes for the A type family. However, K<sub><italic>v</italic></sub>1.1 in conjunction with a K<sub><italic>v</italic></sub>&#x03B2;1 or K<sub><italic>v</italic></sub>1.4 subunit, can have properties of the A type family (<xref ref-type="bibr" rid="B29">D&#x2019;Adamo et al., 2020</xref>). K<sub><italic>v</italic></sub>1 channels are responsible for resetting the resting membrane potential and titrating synaptic release in neurons (<xref ref-type="bibr" rid="B37">Foust et al., 2011</xref>; <xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>). Interestingly, reduced expression of either K<sub><italic>v</italic></sub>1.1 and K<sub><italic>v</italic></sub>1.2 channels have been associated with epilepsy, as each knockout mouse presents with seizures that resemble the development of human epilepsy (<xref ref-type="bibr" rid="B79">Robbins and Tempel, 2012</xref>). Additionally, mutations in K<sub><italic>v</italic></sub> channels that disrupt coassembly with other &#x03B1; or &#x03B2; subunits reduces channel functional and/or expression (<xref ref-type="bibr" rid="B29">D&#x2019;Adamo et al., 2020</xref>). Together, Kv1 channels prevent &#x201C;runaway&#x201D; depolarization, increased firing rates, and excessive neurotransmitter release, all of which can lead to seizures.</p>
<p>It should be noted, that cross referencing the transcriptome of human TSC cortical tubers and those genes with associated epilepsies, transcripts coding for K<sub><italic>v</italic></sub> auxiliary subunits K<sub><italic>v</italic></sub>&#x03B2;1 and K<sub><italic>v</italic></sub>&#x03B2;2 were detected (<xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>; <xref ref-type="bibr" rid="B9">Boer et al., 2010</xref>). Interestingly, other K<sub><italic>v</italic></sub> subunits such as K<sub><italic>v</italic></sub>1.1, K<sub><italic>v</italic></sub>1.2, K<sub><italic>v</italic></sub>1.4, and K<sub><italic>v</italic></sub>4.2 in have been implicated in mTOR-related epilepsy models (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="bibr" rid="B12">Brewster et al., 2013</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). Together, these data suggest that the K<sub><italic>v</italic></sub>1 class should be further investigated in TSC.</p>
</sec>
<sec id="S4.SS1.SSS2">
<title>K<sub><italic>v</italic></sub>4</title>
<p>Among the K<sub><italic>v</italic></sub>4 subunits, <italic>KCND2</italic> (K<sub><italic>v</italic></sub>4.2) and <italic>KCND3</italic> (K<sub><italic>v</italic></sub>4.3) also belong to A-type voltage-gated potassium channel class. These channels are abundantly found in the nervous system within somatodendritic compartment of neurons (<xref ref-type="bibr" rid="B107">Zemel et al., 2018</xref>). Interestingly, several studies have shown that down regulation of the A-current leads to increased excitability (<xref ref-type="bibr" rid="B8">Bernard et al., 2004</xref>; <xref ref-type="bibr" rid="B56">Liu et al., 2014</xref>). For example, a mutation in K<sub><italic>v</italic></sub>4.2 (V404M) leads to impairments in inactivation after channel opening. This mutation has been associated with infant-onset epilepsy and autism (<xref ref-type="bibr" rid="B55">Lin et al., 2018</xref>). Thus, examining the K<sub><italic>v</italic></sub>4 subunit class maybe be a potential interest to TSC and associated seizure types. Altogether, we predict that these channels to be dysfunctional in TSC, specifically the potassium genes listed in <xref ref-type="table" rid="T1">Tables 1</xref>&#x2013;<xref ref-type="table" rid="T3">3</xref>.</p>
</sec>
<sec id="S4.SS1.SSS3">
<title>The role of mTOR in regulating Kv channel expression</title>
<p>Since the discovery of on demand local protein synthesis occurring at the synapse, dysregulation of protein synthesis can lead to misexpression of ion channel subunits and alter the membrane potential and consequently lead to seizure-like conditions (<xref ref-type="bibr" rid="B89">Switon et al., 2017</xref>). Pathways involving mTOR, are known to regulate local synthesis at the synapse. Under conditions where mTOR is active, local synthesis of K<sub><italic>v</italic></sub>1.1 is repressed on dendrites without altering axonal expression (<xref ref-type="bibr" rid="B74">Raab-Graham et al., 2006</xref>; <xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). Additionally, others have shown that both K<sub><italic>v</italic></sub>1.2, and K<sub><italic>v</italic></sub>&#x03B2;2 at the synapse are reduced when mTOR is active (<xref ref-type="bibr" rid="B65">Niere and Raab-Graham, 2017</xref>). Together, these findings suggest that mTOR activity toggles expression of potassium channels as a local feedback mechanism that ensures optimized synaptic function (<xref ref-type="bibr" rid="B73">Raab-Graham and Niere, 2017</xref>).</p>
<p>If mTOR activity is left unregulated, as seen in TSC, repression of K<sub><italic>v</italic></sub> channel expression may lead to an increase in neuronal excitability and to eventual epileptogenesis (<xref ref-type="bibr" rid="B20">Cho, 2011</xref>; <xref ref-type="bibr" rid="B61">Meng et al., 2013</xref>; <xref ref-type="bibr" rid="B47">Jeong and Wong, 2016</xref>). This is suggested by Brewster and colleagues who utilized a model of pilocarpine-induced status epilepticus (SE) model and examined ion channel expression in presence and absence of rapamycin, an mTOR inhibitor. With the development of epileptogenesis, reduced expression of K<sub><italic>v</italic></sub>1.4 and K<sub><italic>v</italic></sub>4.2 in the hippocampus was observed. With the addition of rapamycin, which has been shown to reduce seizure frequency (<xref ref-type="bibr" rid="B109">Zeng et al., 2009</xref>) in SE rodents, protein levels of K<sub><italic>v</italic></sub>1.4 and K<sub><italic>v</italic></sub>4.2 increases to similar levels as seen in the vehicle treated rodents (<xref ref-type="bibr" rid="B12">Brewster et al., 2013</xref>). Altogether, these independent studies indicate that alterations in K<sub><italic>v</italic></sub> expression could result in altered neuronal excitability and further studies are needed to implicate K<sub><italic>v</italic></sub> channels to seizures such as those experienced in TSC.</p>
</sec>
</sec>
<sec id="S4.SS2">
<title>Voltage gated sodium channels</title>
<p>Voltage-gated sodium channels are responsible for the generation and the propagation of action potentials along nerve cells (<xref ref-type="bibr" rid="B17">Catterall, 2000</xref>; <xref ref-type="bibr" rid="B18">Catterall et al., 2005</xref>). Mutations in sodium channel genes most commonly augment neuronal excitability leading to epilepsy (<xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref>). The sodium channel is a transmembrane channel consisting of an &#x03B1; subunit and an auxiliary &#x03B2; subunit (<xref ref-type="bibr" rid="B103">Yu and Catterall, 2003</xref>; <xref ref-type="bibr" rid="B58">Mantegazza and Catterall, 2012</xref>). The &#x03B1; subunit contains four homologous domains composed of a voltage-sensing component and a pore-forming component which undergoes modifications by the auxiliary &#x03B2; subunit (<xref ref-type="bibr" rid="B17">Catterall, 2000</xref>; <xref ref-type="bibr" rid="B18">Catterall et al., 2005</xref>). There are nine sodium channel isoforms; however, only the sodium channels directly implicated in excitability will be mentioned here (<xref ref-type="table" rid="T3">Table 3</xref>), and described below.</p>
<sec id="S4.SS2.SSS1">
<title>Na<sub><italic>v</italic></sub>1.1 and Na<sub><italic>v</italic></sub>1.2</title>
<p>Of interest are Na<sub><italic>v</italic></sub>1.1 and Na<sub><italic>v</italic></sub>1.2, channels expressed in neurons, but more specifically the gene mutations affecting the &#x03B1; subunits of these channels. These mutations lead to inherited forms of epilepsy that differ based on type of &#x03B1; subunit defect (<xref ref-type="bibr" rid="B58">Mantegazza and Catterall, 2012</xref>). The <italic>SCN1A</italic> gene, which encodes the Na<sub><italic>v</italic></sub>1.1 channel, has been associated with Dravet syndrome, which displays afebrile intractable seizures (<xref ref-type="bibr" rid="B23">Craig et al., 2012</xref>; <xref ref-type="bibr" rid="B80">Schmunk and Gargus, 2013</xref>). Missense mutations in the <italic>SCN1A</italic> gene (D322N), commonly display gain of function (GOF), that lead to enhanced sodium currents as a result of lack of inhibition on excitatory neurons (<xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref>). Likewise, mutations in the <italic>SCN2A</italic> gene (A467T), that encodes the voltage-gated sodium channel Na<sub><italic>v</italic></sub>1.2, have been shown to elicit seizure behavior such as in generalized epilepsy with febrile seizure plus (GEFS+) syndrome by also enhancing sodium currents (<xref ref-type="bibr" rid="B80">Schmunk and Gargus, 2013</xref>; <xref ref-type="bibr" rid="B97">Wolff et al., 2017</xref>). Additionally, LOF mutations in <italic>SCN2A</italic> have been linked to ASD and intellectual disability, all of which are commonly seen in patients with TSC. Thus, further research is needed to understand the mechanisms by which mutations in these genes leads to TSC.</p>
</sec>
<sec id="S4.SS2.SSS2">
<title>Na<sub><italic>v</italic></sub>1.3, Na<sub><italic>v</italic></sub>1.6, and Na<sub><italic>v</italic></sub>1.7</title>
<p>Other voltage-gated sodium channels, such as Na<sub><italic>v</italic></sub>1.6 and Na<sub><italic>v</italic></sub>1.7 are associated with infantile spasms and febrile seizures, respectively, while Na<sub><italic>v</italic></sub>1.3 has been associated with patients with epilepsy (<xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref>). Notably, mutations in <italic>SCN8A</italic> gene, coding for Na<sub><italic>v</italic></sub>1.6, affects the action potential threshold which increases spontaneous and repetitive firing leading to an increase in excitability (<xref ref-type="bibr" rid="B60">Menezes et al., 2020</xref>). Additionally, GOF and LOF mutations in Na<sub><italic>v</italic></sub>1.3 and Na<sub><italic>v</italic></sub>1.7, have been reported to alter the biophysical properties of neurons as these genes modify other sodium channels such as Na<sub><italic>v</italic></sub>1.1, which can contribute to pathogenesis of epilepsy, whoever, more studies are needed to ascertain their direct involvement. Altogether, these channels are associated with types of seizures experienced within TSC, however, these channels remain uninvestigated, making these channels possible candidates to examine in TSC.</p>
</sec>
</sec>
<sec id="S4.SS3">
<title>Voltage-gated calcium ion channels</title>
<sec id="S4.SS3.SSS1">
<title>Speculated voltage-gated ion channels in TSC associated epilepsy</title>
<p>Voltage-gated calcium channels are required for different functions in the neuron, such as controlling neuronal excitability and regulating calcium-sensitive intracellular pathways (<xref ref-type="bibr" rid="B15">Cain and Snutch, 2012</xref>; <xref ref-type="bibr" rid="B106">Zamponi et al., 2015</xref>). There are three classes of voltage-gated calcium channels, Ca<sub><italic>v</italic></sub>1, Ca<sub><italic>v</italic></sub>2, and Ca<sub><italic>v</italic></sub>3 (<xref ref-type="table" rid="T3">Table 3</xref>). Each class has subclasses of ion channel expression that vary based function, and kinetics. The channels are either high voltage (HVA) or low voltage activated (LVA), meaning the channel opens or activates at &#x2212;40 and &#x2212;60 mV, respectively (<xref ref-type="bibr" rid="B15">Cain and Snutch, 2012</xref>). The calcium channel, like the sodium and potassium channel, contain an &#x03B1; subunit that stands as the pore-forming unit that is selective for calcium (<xref ref-type="bibr" rid="B15">Cain and Snutch, 2012</xref>; <xref ref-type="bibr" rid="B106">Zamponi et al., 2015</xref>). They also have auxiliary subunits &#x03B2;, &#x03B3; and &#x03B1;2&#x03B4; that regulate the properties of the channel (<xref ref-type="bibr" rid="B16">Campiglio and Flucher, 2015</xref>). Because of the genetic diversity among the calcium channels, only a select few of the channels expressed in the brain will be discussed, specifically the HVA and LVA channel subunits listed in <xref ref-type="table" rid="T1">Tables 1</xref>&#x2013;<xref ref-type="table" rid="T3">3</xref>.</p>
<p>The &#x03B2; auxiliary subunits play an important role in enhancing the biophysical properties of the &#x03B1; subunit, such as channel folding, channel trafficking, and alters gating kinetics and voltage-dependence (<xref ref-type="bibr" rid="B31">Dolphin, 2003</xref>, <xref ref-type="bibr" rid="B32">2016</xref>). Interestingly, our comparison of the human TSC cortical tuber transcriptome cross referenced with genes associated with epilepsies, yielded elevated mRNA coding for Ca<sub><italic>v</italic></sub>&#x03B2;2 and Ca<sub><italic>v</italic></sub>&#x03B2;4 (<xref ref-type="table" rid="T1">Table 1</xref>; <xref ref-type="bibr" rid="B9">Boer et al., 2010</xref>). Interestingly, one study demonstrated that ablation of Ca<sub><italic>v</italic></sub>&#x03B2;1, Ca<sub><italic>v</italic></sub>&#x03B2;2, and Ca<sub><italic>v</italic></sub>&#x03B2;3 have no major impact on neuronal function (<xref ref-type="bibr" rid="B4">Ball et al., 2002</xref>; <xref ref-type="bibr" rid="B90">Vergnol et al., 2022</xref>). On the other hand, one study demonstrated Ca<sub><italic>v</italic></sub>&#x03B2;4 is associated with the <italic>lethargic</italic> mouse model of epilepsy (<xref ref-type="bibr" rid="B13">Burgess et al., 1997</xref>; <xref ref-type="bibr" rid="B90">Vergnol et al., 2022</xref>), while another study showed that disruption in the Ca<sub><italic>v</italic></sub>&#x03B2;2 gene leads to diminished L-type channel currents (<xref ref-type="bibr" rid="B96">Weissgerber et al., 2006</xref>). Although the biophysical properties of these two subunits have yet to be determined in TSC, this finding shows possible insights into voltage-gated calcium channels and whether they are disrupted.</p>
</sec>
<sec id="S4.SS3.SSS2">
<title>Ca<sub><italic>v</italic></sub>2</title>
<p>The Cav2 family encompasses Ca<sub><italic>v</italic></sub>2.1, Ca<sub><italic>v</italic></sub>2.2, and Ca<sub><italic>v</italic></sub>2.3 isoforms. these channels are comprised of a pore-forming &#x03B1; subunit and auxiliary &#x03B2; subunits. Together, they are responsible for regulating Ca2+ entry in response to depolarization and release of neurotransmitters (<xref ref-type="bibr" rid="B63">Mochida, 2019</xref>). These channels can undergo alternative splicing, and thus, have a wide spectrum of biophysical properties. Of particular interest are Ca<sub><italic>v</italic></sub>2.1 and Ca<sub><italic>v</italic></sub>2.3, as shown in <xref ref-type="table" rid="T3">Table 3</xref>, will be discussed further as these channels have more direct implications to seizure. There are several Ca<sub><italic>v</italic></sub>2.1 channel mutations that generate epileptic phenotypes commonly seen within TSC. For example, TSC patients can suffer from absence epilepsy, whose mouse models, &#x201C;leaner&#x201D;, &#x201C;tottering&#x201D;, and &#x201C;rocker,&#x201D; display epileptic phenotypes as a result of different Ca<sub><italic>v</italic></sub>2.1 channel mutations (<xref ref-type="bibr" rid="B45">Imbrici et al., 2004</xref>; <xref ref-type="bibr" rid="B63">Mochida, 2019</xref>). These mutations affect Ca<sub><italic>v</italic></sub>2.1 current density by slowing channel inactivation as well as imbalances on inhibitory to excitatory neurotransmission leading to increased firing (<xref ref-type="bibr" rid="B76">Rajakulendran and Hanna, 2016</xref>). Similarly, Ca<sub><italic>v</italic></sub>2.3 has also been demonstrated to play a role in absence epilepsy role (<xref ref-type="bibr" rid="B105">Zaman et al., 2011</xref>). Nevertheless, the contribution of Ca<sub><italic>v</italic></sub>2.1 or Ca<sub><italic>v</italic></sub>2.3 to TSC absence epilepsy remains to be determined and, thus, this remains a possible avenue of exploration.</p>
</sec>
<sec id="S4.SS3.SSS3">
<title>Ca<sub><italic>v</italic></sub>3</title>
<p>T-type calcium channels, do not require auxiliary subunits (<xref ref-type="bibr" rid="B83">Simms and Zamponi, 2014</xref>). Because the Ca<sub><italic>v</italic></sub>3 subunits have been shown to undergo alternative splicing, resulting in channel function diversity, the T-type channels that will be discussed in the context of TSC will be Ca<sub><italic>v</italic></sub>3.1 (<italic>CACNA1G)</italic> and Ca<sub><italic>v</italic></sub>3.2 (<italic>CACNA1H)</italic>. <italic>CACNA1G</italic> channels are highly expressed in thalamocortical (TC) neurons (<xref ref-type="bibr" rid="B19">Chen et al., 2014</xref>). <italic>CACNA1H</italic> has been shown to be primarily expressed in the dorsal root ganglion, dentate of the hippocampus, and thalamus (<xref ref-type="bibr" rid="B39">Graef et al., 2011</xref>; <xref ref-type="bibr" rid="B83">Simms and Zamponi, 2014</xref>; <xref ref-type="bibr" rid="B7">Bernal Sierra et al., 2017</xref>). Ca<sub><italic>v</italic></sub>3.2 mutations have been shown to lead to seizures in murine models, specifically absence epilepsy. Because of this implication in seizure commonality, and because this limbic seizure can precede from subcortical structures such as the thalamus, it is possible that T-channels play a role in initiating the spread to higher structures in the TSC brain.</p>
</sec>
<sec id="S4.SS3.SSS4">
<title>Ca<sub><italic>V</italic></sub> channel expression in TSC</title>
<p>As previously mentioned above, the HVA class also encompasses L-type calcium channels as they are integral to cell&#x2019;s membrane complex that mediate influx of Ca2+ after a depolarization response (<xref ref-type="bibr" rid="B42">Hofmann et al., 2014</xref>). The &#x201C;L&#x201D; in L-type represents the long-lasting inward currents during depolarization which have distinguished them from their &#x201C;transient current&#x201D; T-type cousins (<xref ref-type="bibr" rid="B106">Zamponi et al., 2015</xref>). One L-type channel, Ca<sub><italic>v</italic></sub>1.2, is composed of three subunits &#x03B1;1, &#x03B1;2&#x03B4;, and &#x03B2; axillary subunits (<xref ref-type="bibr" rid="B42">Hofmann et al., 2014</xref>; <xref ref-type="bibr" rid="B106">Zamponi et al., 2015</xref>), and may provide more insight into TSC epileptic phenotypes. There have been case studies indicating the presence of febrile seizures among TSC patients (<xref ref-type="bibr" rid="B52">Kubo et al., 2011</xref>; <xref ref-type="bibr" rid="B82">Siddaraju et al., 2016</xref>). However, these case studies primarily served as documentation for the patients&#x2019; condition, and no other studies have followed up on the possibilities of febrile seizures in TSC models. Interestingly, one independent study demonstrated that febrile seizures in rat pups may be prevented with the use of nimodipine (<xref ref-type="bibr" rid="B75">Radzicki et al., 2013</xref>). Additionally, mTOR hyperactivation has been shown to differentially regulate L channel expression in TSC. An independent study has demonstrated that somatic Ca<sub><italic>v</italic></sub>1.2 and Ca<sub><italic>v</italic></sub>1.3 gene and protein expression are augmented in TSC2-null neurons. <xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref> also demonstrates that Cav1.3 triggers enhanced neuronal activity of TSC2<sup>&#x2013;/&#x2013;</sup> neurons and could be a potential novel target for epilepsy in TSC (<xref ref-type="bibr" rid="B41">Hisatsune et al., 2021</xref>). On the other hand, Ca<sub><italic>v</italic></sub>1.2 <italic>de novo</italic> protein synthesis was found to be reduced in the dendrites of hippocampal CA-1 neurons in a mouse model of TSC1 (<xref ref-type="fig" rid="F2">Figure 2</xref>). Furthermore, <xref ref-type="bibr" rid="B66">Niere et al. (2023)</xref> found that an RNA binding protein DJ-1 coordinates the expression of Ca<sub><italic>v</italic></sub> channel complex, including Cav1.2 and &#x03B1;2&#x03B4;2, resulting in attenuated calcium signaling in the dendrites (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="table" rid="T2">Table 2</xref>). Like the &#x03B2; subunits mentioned above, the &#x03B1;2&#x03B4; auxiliary subunits play an important role in trafficking and gating of the &#x03B1; subunits (<xref ref-type="bibr" rid="B31">Dolphin, 2003</xref>, <xref ref-type="bibr" rid="B32">2016</xref>). Additionally, &#x03B1;2&#x03B4;1 was found to be overexpressed in conditionally knockout TSC hippocampal dendrites (<xref ref-type="bibr" rid="B66">Niere et al., 2023</xref>); however its role in TSC has not been established. Together, these two studies on L-type calcium channels, suggest that subcellular localization of these channels differentially affects calcium influx across the cell. Considering the importance of calcium channel to seizures, these findings give credence to further investigation of calcium channel dysfunction in TSC.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Tsc1 cKO mouse model exhibits decreased <italic>de novo</italic> protein synthesis of Ca<sub>V</sub>1.2 <italic>&#x03B1;2&#x03B4;2, but not &#x03B1;2&#x03B4;1</italic> (40). De novo protein synthesis, visualized by Surface Sensing of Translation-Proximity Ligation Assay (SUnSET-PLA) (green) in hippocampal dendrites (MAP2, red). The SUnSET-PLA combinatory assay labels newly synthesized Ca<sub>V</sub>1.2, &#x03B1;2&#x03B4;2, and &#x03B1;2&#x03B4;1 proteins in the hippocampus by detecting puromycin (which binds and halts translation) on a translating ribosome and the translating protein with a specific antibody. This assay allows one to separate new protein from already synthesize protein. WT (W) and TSC (T) dendrites are outlined by broken lines. <bold>(A)</bold> Basal Ca<sub>V</sub>1.2 protein synthesis is detected in dendrites of WT is markedly reduced in TSC. <bold>(B)</bold> &#x03B1;2&#x03B4;2 basal new protein synthesis is detected in dendrites of WT but is attenuated in TSC. <bold>(C)</bold> Basal &#x03B1;2&#x03B4;1 protein synthesis in dendrites of WT is lower than TSC. For representative images in panel <bold>(A)</bold> through panel <bold>(C)</bold>, Ca<sub>V</sub>1.2, &#x03B1;2&#x03B4;2, and &#x03B1;2&#x03B4;1 puncta were dilated once using ImageJ. Adapted from <xref ref-type="bibr" rid="B66">Niere et al. (2023)</xref>. Bar values represent mean &#x00B1; SEM. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-17-1404884-g002.tif"/>
</fig>
</sec>
</sec>
</sec>
<sec id="S5" sec-type="conclusion">
<title>Conclusion</title>
<p>In conclusion, the disruption of voltage-gated ion channels leads to different types of seizures. mTOR, downstream of the TSC, has been shown to be involved in regulating ion channel expression, and may contribute to epileptogenesis. Because of the complexity each voltage-gated ion channel, there are many unanswered questions of their role in TSC. Yet, understanding the contribution from each voltage-gated ion channel may provide insight into the heterogeneity of seizures in TSC and possibly determine new therapeutic targets of interest.</p>
</sec>
<sec id="S6">
<title>Scope statement</title>
<p>Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder that results in hyperactive mammalian/mechanistic target of rapamycin (mTOR) signaling leading to altered neuronal excitability and seizures; however, the underlying mechanisms remain a mystery. Several potassium, sodium, or calcium voltage-gated channels have been found to be causative in disorders that result in aberrant neuronal excitability and seizures. Surprisingly, these channels remain understudied in TSC-associated neuronal dysfunction. The coordination of these ionic conductances, dictated by the channel&#x2019;s expression, subcellular localization, and biophysical properties, keep neurons operating in an optimal range, providing network stability. Our review examines the current TSC literature describing common seizure types, clinical trials, and genomic studies that potentially implicate potassium, sodium, and calcium voltage-gated channel dysfunction in TSC. Notably, the expression of several voltage-gated ion channels and auxiliary subunits have been shown to be regulated by mTOR signaling, arguing for further studies of ion channel dysfunction in TSC. <italic>Frontiers in Molecular Neuroscience-Molecular Signalling and Pathways</italic> is particularly interested in topics that pertain to brain disease mechanisms such as TSC, molecular signaling pathways such as mTOR, and synaptic and cellular proteins such as voltage-gated ion channels.</p>
</sec>
<sec id="S7" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="S8" sec-type="author-contributions">
<title>Author contributions</title>
<p>HE-B: Conceptualization, Data curation, Writing &#x2013; original draft, Writing &#x2013; review and editing. RS: Writing &#x2013; review and editing. KR-G: Conceptualization, Funding acquisition, Supervision, Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
</body>
<back>
<sec id="S9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by NIH NIAAA R01 AA029691 (KR-G), NIH NINDS NS105005 (KR-G), NS105005-03S1 (KR-G); USAMRMC Award W81XWH-14-1-0061 and W81XWH-19-1-0202 (KR-G), NIAAA T32AA007565 (HE-B), and NIDA T32DA041349 (HE-B). Funding from the WFUSM Neuroscience Clinical Trial and Innovation Center (KR-G and RS).</p>
</sec>
<ack><p>We would like to thank Dr. Dwayne Godwin for providing insight on T-channels.</p>
</ack>
<sec id="S10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="S11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alliance</surname> <given-names>T. S.</given-names></name></person-group> (<year>2020</year>). <source><italic>Infantile spasms [Online].</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/infantile-spasms/">https://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/infantile-spasms/</ext-link> <comment>(accessed October 06, 2020)</comment>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almobarak</surname> <given-names>S.</given-names></name> <name><surname>Almuhaizea</surname> <given-names>M.</given-names></name> <name><surname>Abukhaled</surname> <given-names>M.</given-names></name> <name><surname>Alyamani</surname> <given-names>S.</given-names></name> <name><surname>Dabbagh</surname> <given-names>O.</given-names></name> <name><surname>Chedrawi</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Tuberous sclerosis complex: Clinical spectrum and epilepsy: A retrospective chart review study.</article-title> <source><italic>Transl. Neurosci.</italic></source> <volume>9</volume> <fpage>154</fpage>&#x2013;<lpage>160</lpage>.</citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appleton</surname> <given-names>R. E.</given-names></name></person-group> (<year>2011</year>). <source><italic>Tsc and epilepsy [Online].</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://tuberous-sclerosis.org/wp-content/uploads/2019/10/TSA-TSC-and-epilepsy.pdf">https://tuberous-sclerosis.org/wp-content/uploads/2019/10/TSA-TSC-and-epilepsy.pdf</ext-link> <comment>(accessed October 6, 2020)</comment>.</citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname> <given-names>S. L.</given-names></name> <name><surname>Powers</surname> <given-names>P. A.</given-names></name> <name><surname>Shin</surname> <given-names>H. S.</given-names></name> <name><surname>Morgans</surname> <given-names>C. W.</given-names></name> <name><surname>Peachey</surname> <given-names>N. S.</given-names></name> <name><surname>Gregg</surname> <given-names>R. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Role of the beta(2) subunit of voltage-dependent calcium channels in the retinal outer plexiform layer.</article-title> <source><italic>Invest. Ophthalmol. Vis. Sci.</italic></source> <volume>43</volume> <fpage>1595</fpage>&#x2013;<lpage>1603</lpage>.</citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bateup</surname> <given-names>H. S.</given-names></name> <name><surname>Johnson</surname> <given-names>C. A.</given-names></name> <name><surname>Denefrio</surname> <given-names>C. L.</given-names></name> <name><surname>Saulnier</surname> <given-names>J. L.</given-names></name> <name><surname>Kornacker</surname> <given-names>K.</given-names></name> <name><surname>Sabatini</surname> <given-names>B. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.</article-title> <source><italic>Neuron</italic></source> <volume>78</volume> <fpage>510</fpage>&#x2013;<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.017</pub-id> <pub-id pub-id-type="pmid">23664616</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bebin</surname> <given-names>E. M.</given-names></name> <name><surname>Peters</surname> <given-names>J. M.</given-names></name> <name><surname>Porter</surname> <given-names>B. E.</given-names></name> <name><surname>Mcpherson</surname> <given-names>T. O.</given-names></name> <name><surname>O&#x2019;kelley</surname> <given-names>S.</given-names></name> <name><surname>Sahin</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Early treatment with vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: The prevent trial.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>95</volume>, <fpage>15</fpage>&#x2013;<lpage>26</lpage>.</citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernal Sierra</surname> <given-names>Y. A.</given-names></name> <name><surname>Haseleu</surname> <given-names>J.</given-names></name> <name><surname>Kozlenkov</surname> <given-names>A.</given-names></name> <name><surname>B&#x00E9;gay</surname> <given-names>V.</given-names></name> <name><surname>Lewin</surname> <given-names>G. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic Tracing of Ca(v)3.2 T-type calcium channel expression in the peripheral nervous system.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>10</volume>:<issue>70</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00070</pub-id> <pub-id pub-id-type="pmid">28360836</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname> <given-names>C.</given-names></name> <name><surname>Anderson</surname> <given-names>A.</given-names></name> <name><surname>Becker</surname> <given-names>A.</given-names></name> <name><surname>Poolos</surname> <given-names>N. P.</given-names></name> <name><surname>Beck</surname> <given-names>H.</given-names></name> <name><surname>Johnston</surname> <given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Acquired dendritic channelopathy in temporal lobe epilepsy.</article-title> <source><italic>Science</italic></source> <volume>305</volume> <fpage>532</fpage>&#x2013;<lpage>535</lpage>.</citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname> <given-names>K.</given-names></name> <name><surname>Crino</surname> <given-names>P. B.</given-names></name> <name><surname>Gorter</surname> <given-names>J. A.</given-names></name> <name><surname>Nellist</surname> <given-names>M.</given-names></name> <name><surname>Jansen</surname> <given-names>F. E.</given-names></name> <name><surname>Spliet</surname> <given-names>W. G. M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors.</article-title> <source><italic>Brain Pathol.</italic></source> <volume>20</volume> <fpage>704</fpage>&#x2013;<lpage>719</lpage>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bollo</surname> <given-names>R. J.</given-names></name> <name><surname>Kalhorn</surname> <given-names>S. P.</given-names></name> <name><surname>Carlson</surname> <given-names>C.</given-names></name> <name><surname>Haegeli</surname> <given-names>V.</given-names></name> <name><surname>Devinsky</surname> <given-names>O.</given-names></name> <name><surname>Weiner</surname> <given-names>H. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Epilepsy surgery and tuberous sclerosis complex: Special considerations.</article-title> <source><italic>Neurosurg. Focus</italic></source> <volume>25</volume>:<issue>E13</issue>.</citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boutry-Kryza</surname> <given-names>N.</given-names></name> <name><surname>Labalme</surname> <given-names>A.</given-names></name> <name><surname>Ville</surname> <given-names>D.</given-names></name> <name><surname>De Bellescize</surname> <given-names>J.</given-names></name> <name><surname>Touraine</surname> <given-names>R.</given-names></name> <name><surname>Prieur</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Molecular characterization of a cohort of 73 patients with infantile spasms syndrome.</article-title> <source><italic>Eur. J. Med. Genet.</italic></source> <volume>58</volume> <fpage>51</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2014.11.007</pub-id> <pub-id pub-id-type="pmid">25497044</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brewster</surname> <given-names>A. L.</given-names></name> <name><surname>Lugo</surname> <given-names>J. N.</given-names></name> <name><surname>Patil</surname> <given-names>V. V.</given-names></name> <name><surname>Lee</surname> <given-names>W. L.</given-names></name> <name><surname>Qian</surname> <given-names>Y.</given-names></name> <name><surname>Vanegas</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<issue>e57808</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0057808</pub-id> <pub-id pub-id-type="pmid">23536771</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname> <given-names>D. L.</given-names></name> <name><surname>Jones</surname> <given-names>J. M.</given-names></name> <name><surname>Meisler</surname> <given-names>M. H.</given-names></name> <name><surname>Noebels</surname> <given-names>J. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Mutation of the Ca2+ channel &#x03B2; subunit gene cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse.</article-title> <source><italic>Cell</italic></source> <volume>88</volume> <fpage>385</fpage>&#x2013;<lpage>392</lpage>.</citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burkhalter</surname> <given-names>A.</given-names></name> <name><surname>Gonchar</surname> <given-names>Y.</given-names></name> <name><surname>Mellor</surname> <given-names>R. L.</given-names></name> <name><surname>Nerbonne</surname> <given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Differential expression of I(A) channel subunits Kv4.2 and Kv4.3 in mouse visual cortical neurons and synapses.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>26</volume> <fpage>12274</fpage>&#x2013;<lpage>12282</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2599-06.2006</pub-id> <pub-id pub-id-type="pmid">17122053</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname> <given-names>S. M.</given-names></name> <name><surname>Snutch</surname> <given-names>T. P.</given-names></name></person-group> (<year>2012</year>). <source><italic>Voltage-gated calcium channels in epilepsy. Jasper&#x2019;s basic mechanisms of the epilepsies</italic></source>, <edition>4th Edn</edition>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information (US)</publisher-name>.</citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campiglio</surname> <given-names>M.</given-names></name> <name><surname>Flucher</surname> <given-names>B. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The Role of Auxiliary Subunits for the Functional Diversity of Voltage-Gated Calcium Channels.</article-title> <source><italic>J. Cell. Physiol.</italic></source> <volume>230</volume> <fpage>2019</fpage>&#x2013;<lpage>2031</lpage>.</citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname> <given-names>W. A.</given-names></name></person-group> (<year>2000</year>). <article-title>From ionic currents to molecular mechanisms.</article-title> <source><italic>Neuron</italic></source> <volume>26</volume> <fpage>13</fpage>&#x2013;<lpage>25</lpage>.</citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname> <given-names>W. A.</given-names></name> <name><surname>Goldin</surname> <given-names>A. L.</given-names></name> <name><surname>Waxman</surname> <given-names>S. G.</given-names></name></person-group> (<year>2005</year>). <article-title>International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.</article-title> <source><italic>Pharmacol. Rev.</italic></source> <volume>57</volume>:<issue>397</issue>. <pub-id pub-id-type="doi">10.1124/pr.57.4.4</pub-id> <pub-id pub-id-type="pmid">16382098</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Parker</surname> <given-names>W. D.</given-names></name> <name><surname>Wang</surname> <given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of T-type calcium channel genes in absence seizures.</article-title> <source><italic>Front. Neurol.</italic></source> <volume>5</volume> <fpage>45</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.3389/fneur.2014.00045</pub-id> <pub-id pub-id-type="pmid">24847307</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>C.-H.</given-names></name></person-group> (<year>2011</year>). <article-title>Frontier of epilepsy research - mtor signaling pathway.</article-title> <source><italic>Exp. Mol. Med.</italic></source> <volume>43</volume> <fpage>231</fpage>&#x2013;<lpage>274</lpage>.</citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christel</surname> <given-names>C. J.</given-names></name> <name><surname>Cardona</surname> <given-names>N.</given-names></name> <name><surname>Mesirca</surname> <given-names>P.</given-names></name> <name><surname>Herrmann</surname> <given-names>S.</given-names></name> <name><surname>Hofmann</surname> <given-names>F.</given-names></name> <name><surname>Striessnig</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node.</article-title> <source><italic>J. Physiol.</italic></source> <volume>590</volume> <fpage>6327</fpage>&#x2013;<lpage>6342</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2012.239954</pub-id> <pub-id pub-id-type="pmid">23045342</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>E. C.</given-names></name></person-group> (<year>2012</year>). <source><italic>Potassium channels (including Kcnq) and epilepsy. Jasper&#x2019;s basic mechanisms of the epilepsies</italic></source>, <edition>4th Edn</edition>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information (US)</publisher-name>.</citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname> <given-names>A. K.</given-names></name> <name><surname>De Menezes</surname> <given-names>M. S.</given-names></name> <name><surname>Saneto</surname> <given-names>R. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Dravet syndrome: Patients with co-morbid Scn1A gene mutations and mitochondrial electron transport chain defects.</article-title> <source><italic>Seizure Eur. J. Epilepsy</italic></source> <volume>21</volume> <fpage>17</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.seizure.2011.08.010</pub-id> <pub-id pub-id-type="pmid">21906962</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Moavero</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>mTOR inhibitors in tuberous sclerosis complex.</article-title> <source><italic>Curr. Neuropharmacol.</italic></source> <volume>10</volume> <fpage>404</fpage>&#x2013;<lpage>415</lpage>.</citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Bombardieri</surname> <given-names>R.</given-names></name> <name><surname>Jozwiak</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Tuberous sclerosis.</article-title> <source><italic>Lancet</italic></source> <volume>372</volume> <fpage>657</fpage>&#x2013;<lpage>668</lpage>.</citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Moavero</surname> <given-names>R.</given-names></name> <name><surname>De Vries</surname> <given-names>P. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurological and neuropsychiatric aspects of tuberous sclerosis complex.</article-title> <source><italic>Lancet Neurol.</italic></source> <volume>14</volume> <fpage>733</fpage>&#x2013;<lpage>745</lpage>.</citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Moavero</surname> <given-names>R.</given-names></name> <name><surname>Van Scheppingen</surname> <given-names>J.</given-names></name> <name><surname>Aronica</surname> <given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>mTOR dysregulation and tuberous sclerosis-related epilepsy.</article-title> <source><italic>Expert rev. Neurother.</italic></source> <volume>18</volume>:<issue>185</issue>. <pub-id pub-id-type="doi">10.1080/14737175.2018.1428562</pub-id> <pub-id pub-id-type="pmid">29338461</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Seri</surname> <given-names>S.</given-names></name> <name><surname>Verdecchia</surname> <given-names>M.</given-names></name> <name><surname>Bombardieri</surname> <given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Infantile spasms in tuberous sclerosis complex.</article-title> <source><italic>Brain Dev.</italic></source> <volume>23</volume> <fpage>502</fpage>&#x2013;<lpage>507</lpage>.</citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x2019;Adamo</surname> <given-names>M. C.</given-names></name> <name><surname>Liantonio</surname> <given-names>A.</given-names></name> <name><surname>Rolland</surname> <given-names>J. F.</given-names></name> <name><surname>Pessia</surname> <given-names>M.</given-names></name> <name><surname>Imbrici</surname> <given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>21</volume>:<issue>2935</issue>. <pub-id pub-id-type="doi">10.3390/ijms21082935</pub-id> <pub-id pub-id-type="pmid">32331416</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahimene</surname> <given-names>S.</given-names></name> <name><surname>Von Elsner</surname> <given-names>L.</given-names></name> <name><surname>Holling</surname> <given-names>T.</given-names></name> <name><surname>Mattas</surname> <given-names>L. S.</given-names></name> <name><surname>Pickard</surname> <given-names>J.</given-names></name> <name><surname>Lessel</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Biallelic Cacna2D1 loss-of-function variants cause early-onset developmental epileptic encephalopathy.</article-title> <source><italic>Brain</italic></source> <volume>145</volume> <fpage>2721</fpage>&#x2013;<lpage>2729</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awac081</pub-id> <pub-id pub-id-type="pmid">35293990</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname> <given-names>A. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Subunits of voltage-gated calcium channels.</article-title> <source><italic>J. Bioenerget. Biomembr.</italic></source> <volume>35</volume> <fpage>599</fpage>&#x2013;<lpage>620</lpage>.</citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname> <given-names>A. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Voltage-gated calcium channels and their auxiliary subunits: Physiology and pathophysiology and pharmacology.</article-title> <source><italic>J. Physiol.</italic></source> <volume>594</volume> <fpage>5369</fpage>&#x2013;<lpage>5390</lpage>.</citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname> <given-names>A. M.</given-names></name> <name><surname>Mcanelly</surname> <given-names>C. A.</given-names></name> <name><surname>Srinivasan</surname> <given-names>A.</given-names></name> <name><surname>Mueller</surname> <given-names>R. L.</given-names></name> <name><surname>Garrity</surname> <given-names>D. B.</given-names></name> <name><surname>Garrity</surname> <given-names>D. M.</given-names></name></person-group> (<year>2008</year>). <article-title>The calcium channel &#x03B2;2 (Cacnb2) subunit repertoire in teleosts.</article-title> <source><italic>BMC Mol. Biol.</italic></source> <volume>9</volume>:<issue>38</issue>. <pub-id pub-id-type="doi">10.1186/1471-2199-9-38</pub-id> <pub-id pub-id-type="pmid">18419826</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escayg</surname> <given-names>A.</given-names></name> <name><surname>Jones</surname> <given-names>J. M.</given-names></name> <name><surname>Kearney</surname> <given-names>J. A.</given-names></name> <name><surname>Hitchcock</surname> <given-names>P. F.</given-names></name> <name><surname>Meisler</surname> <given-names>M. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Calcium channel &#x03B2;4 (CACNB4): Human ortholog of the mouse epilepsy genelethargic.</article-title> <source><italic>Genomics</italic></source> <volume>50</volume> <fpage>14</fpage>&#x2013;<lpage>22</lpage>.</citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Estacion</surname> <given-names>M.</given-names></name> <name><surname>Gasser</surname> <given-names>A.</given-names></name> <name><surname>Dib-Hajj</surname> <given-names>S. D.</given-names></name> <name><surname>Waxman</surname> <given-names>S. G.</given-names></name></person-group> (<year>2010</year>). <article-title>A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons.</article-title> <source><italic>Exp. Neurol.</italic></source> <volume>224</volume> <fpage>362</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2010.04.012</pub-id> <pub-id pub-id-type="pmid">20420834</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>J.</given-names></name> <name><surname>Gandini</surname> <given-names>M. A.</given-names></name> <name><surname>Zhang</surname> <given-names>F.-X.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Souza</surname> <given-names>I. A.</given-names></name> <name><surname>Zamponi</surname> <given-names>G. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Down-regulation of T-type Cav3.2 channels by hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1): Evidence of a signaling complex.</article-title> <source><italic>Channels</italic></source> <volume>11</volume> <fpage>434</fpage>&#x2013;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1080/19336950.2017.1326233</pub-id> <pub-id pub-id-type="pmid">28467171</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foust</surname> <given-names>A. J.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name> <name><surname>Popovic</surname> <given-names>M.</given-names></name> <name><surname>Zecevic</surname> <given-names>D.</given-names></name> <name><surname>Mccormick</surname> <given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Somatic membrane potential and Kv1 channels control spike repolarization in cortical axon collaterals and presynaptic boutons.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>31</volume> <fpage>15490</fpage>&#x2013;<lpage>15498</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2752-11.2011</pub-id> <pub-id pub-id-type="pmid">22031895</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname> <given-names>D. N.</given-names></name> <name><surname>Lawson</surname> <given-names>J. A.</given-names></name> <name><surname>Yapici</surname> <given-names>Z.</given-names></name> <name><surname>Brandt</surname> <given-names>C.</given-names></name> <name><surname>Kohrman</surname> <given-names>M. H.</given-names></name> <name><surname>Wong</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures.</article-title> <source><italic>Epilepsia</italic></source> <volume>59</volume> <fpage>1188</fpage>&#x2013;<lpage>1197</lpage>. <pub-id pub-id-type="doi">10.1111/epi.14085</pub-id> <pub-id pub-id-type="pmid">29727013</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graef</surname> <given-names>J. D.</given-names></name> <name><surname>Huitt</surname> <given-names>T. W.</given-names></name> <name><surname>Nordskog</surname> <given-names>B. K.</given-names></name> <name><surname>Hammarback</surname> <given-names>J. H.</given-names></name> <name><surname>Godwin</surname> <given-names>D. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Disrupted thalamic T-type Ca2+ channel expression and function during ethanol exposure and withdrawal.</article-title> <source><italic>J. Neurophysiol.</italic></source> <volume>105</volume> <fpage>528</fpage>&#x2013;<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00424.2010</pub-id> <pub-id pub-id-type="pmid">21148095</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinemann</surname> <given-names>S. H.</given-names></name> <name><surname>Rettig</surname> <given-names>J.</given-names></name> <name><surname>Graack</surname> <given-names>H. R.</given-names></name> <name><surname>Pongs</surname> <given-names>O.</given-names></name></person-group> (<year>1996</year>). <article-title>Functional characterization of Kv channel beta-subunits from rat brain.</article-title> <source><italic>J. Physiol.</italic></source> <volume>493</volume> <fpage>625</fpage>&#x2013;<lpage>633</lpage>.</citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hisatsune</surname> <given-names>C.</given-names></name> <name><surname>Shimada</surname> <given-names>T.</given-names></name> <name><surname>Miyamoto</surname> <given-names>A.</given-names></name> <name><surname>Lee</surname> <given-names>A.</given-names></name> <name><surname>Yamagata</surname> <given-names>K.</given-names></name></person-group> (<year>2021</year>). <article-title>Tuberous sclerosis complex (TSC) inactivation increases neuronal network activity by enhancing Ca2+ Influx via L-Type Ca2+ channels.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>41</volume> <fpage>8134</fpage>&#x2013;<lpage>8149</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1930-20.2021</pub-id> <pub-id pub-id-type="pmid">34417327</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname> <given-names>F.</given-names></name> <name><surname>Flockerzi</surname> <given-names>V.</given-names></name> <name><surname>Kahl</surname> <given-names>S.</given-names></name> <name><surname>Wegener</surname> <given-names>J. W.</given-names></name></person-group> (<year>2014</year>). <article-title>L-Type CaV1.2 calcium channels: From in vitro findings to in vivo function.</article-title> <source><italic>Physiol. Rev.</italic></source> <volume>94</volume> <fpage>303</fpage>&#x2013;<lpage>326</lpage>.</citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>L. S.</given-names></name> <name><surname>Wen</surname> <given-names>J. H.</given-names></name> <name><surname>Claycomb</surname> <given-names>K.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Harrsch</surname> <given-names>F. A.</given-names></name> <name><surname>Naegele</surname> <given-names>J. R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>7</volume>:<issue>11753</issue>. <pub-id pub-id-type="doi">10.1038/ncomms11753</pub-id> <pub-id pub-id-type="pmid">27249187</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imbrici</surname> <given-names>P.</given-names></name> <name><surname>D&#x2019;adamo</surname> <given-names>M. C.</given-names></name> <name><surname>Cusimano</surname> <given-names>A.</given-names></name> <name><surname>Pessia</surname> <given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.</article-title> <source><italic>Am. J. Physiol. Cell Physiol.</italic></source> <volume>292</volume> <fpage>C778</fpage>&#x2013;<lpage>C787</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00259.2006</pub-id> <pub-id pub-id-type="pmid">16956965</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imbrici</surname> <given-names>P.</given-names></name> <name><surname>Jaffe</surname> <given-names>S. L.</given-names></name> <name><surname>Eunson</surname> <given-names>L. H.</given-names></name> <name><surname>Davies</surname> <given-names>N. P.</given-names></name> <name><surname>Herd</surname> <given-names>C.</given-names></name> <name><surname>Robertson</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia.</article-title> <source><italic>Brain</italic></source> <volume>127</volume> <fpage>2682</fpage>&#x2013;<lpage>2692</lpage>.</citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarnot</surname> <given-names>M.</given-names></name> <name><surname>Corbett</surname> <given-names>A. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Immunolocalization of NaV1.2 channel subtypes in rat and cat brain and spinal cord with high affinity antibodies.</article-title> <source><italic>Brain Res.</italic></source> <volume>1107</volume> <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2006.05.090</pub-id> <pub-id pub-id-type="pmid">16815341</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname> <given-names>A.</given-names></name> <name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy.</article-title> <source><italic>Expert Rev. Neurother.</italic></source> <volume>16</volume> <fpage>437</fpage>&#x2013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1586/14737175.2016.1151788</pub-id> <pub-id pub-id-type="pmid">26854692</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelleher</surname> <given-names>R. J.</given-names></name> <name><surname>Bear</surname> <given-names>M. F.</given-names></name></person-group> (<year>2008</year>). <article-title>The autistic neuron: Troubled translation?</article-title> <source><italic>Cell</italic></source> <volume>135</volume> <fpage>401</fpage>&#x2013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.10.017</pub-id> <pub-id pub-id-type="pmid">18984149</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiriakopoulos</surname> <given-names>E. S.</given-names></name> <name><surname>Osborne</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <source><italic>Types of seizures [Online]. Epilepsy Foundation.</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.epilepsy.com/learn/types-seizures">https://www.epilepsy.com/learn/types-seizures</ext-link> <comment>(accessed June 6, 2020)</comment>.</citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kothare Sanjeev</surname> <given-names>V.</given-names></name> <name><surname>Singh</surname> <given-names>K.</given-names></name> <name><surname>Chalifoux Jason</surname> <given-names>R.</given-names></name> <name><surname>Staley Brigid</surname> <given-names>A.</given-names></name> <name><surname>Weiner Howard</surname> <given-names>L.</given-names></name> <name><surname>Menzer</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Severity of manifestations in tuberous sclerosis complex in relation to genotype.</article-title> <source><italic>Epilepsia</italic></source> <volume>55</volume> <fpage>1025</fpage>&#x2013;<lpage>1029</lpage>.</citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotulska</surname> <given-names>K.</given-names></name> <name><surname>Kwiatkowski</surname> <given-names>D. J.</given-names></name> <name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Weschke</surname> <given-names>B.</given-names></name> <name><surname>Riney</surname> <given-names>K.</given-names></name> <name><surname>Jansen</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>89</volume> <fpage>304</fpage>&#x2013;<lpage>314</lpage>.</citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname> <given-names>M.</given-names></name> <name><surname>Iwashita</surname> <given-names>K.</given-names></name> <name><surname>Oyachi</surname> <given-names>N.</given-names></name> <name><surname>Oyama</surname> <given-names>T.</given-names></name> <name><surname>Yamamoto</surname> <given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Two different types of infantile renal cell carcinomas associated with tuberous sclerosis.</article-title> <source><italic>J. Pediatr. Surg.</italic></source> <volume>46</volume> <fpage>e37</fpage>&#x2013;<lpage>e41</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpedsurg.2011.06.035</pub-id> <pub-id pub-id-type="pmid">22008361</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lasarge</surname> <given-names>C. L.</given-names></name> <name><surname>Danzer</surname> <given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanisms regulating neuronal excitability and seizure development following mtor pathway hyperactivation.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>7</volume>:<issue>18</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2014.00018</pub-id> <pub-id pub-id-type="pmid">24672426</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Lin</surname> <given-names>M. C.</given-names></name> <name><surname>Kornblum</surname> <given-names>H. I.</given-names></name> <name><surname>Papazian</surname> <given-names>D. M.</given-names></name> <name><surname>Nelson</surname> <given-names>S. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Exome sequencing identifies de novo gain of function missense mutation in Kcnd2 in identical twins with autism and seizures that slows potassium channel inactivation.</article-title> <source><italic>Hum. Mol. Genet.</italic></source> <volume>23</volume> <fpage>3481</fpage>&#x2013;<lpage>3489</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu056</pub-id> <pub-id pub-id-type="pmid">24501278</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>M. A.</given-names></name> <name><surname>Cannon</surname> <given-names>S. C.</given-names></name> <name><surname>Papazian</surname> <given-names>D. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Kv4.2 autism and epilepsy mutation enhances inactivation of closed channels but impairs access to inactivated state after opening.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>115</volume> <fpage>E3559</fpage>&#x2013;<lpage>E3568</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1717082115</pub-id> <pub-id pub-id-type="pmid">29581270</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y. Q.</given-names></name> <name><surname>Huang</surname> <given-names>W. X.</given-names></name> <name><surname>Sanchez</surname> <given-names>R. M.</given-names></name> <name><surname>Min</surname> <given-names>J. W.</given-names></name> <name><surname>Hu</surname> <given-names>J. J.</given-names></name> <name><surname>He</surname> <given-names>X. H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Regulation of Kv4.2 A-type potassium channels in HEK-293 cells by hypoxia.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>8</volume>:<issue>329</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00329</pub-id> <pub-id pub-id-type="pmid">25352783</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>D. S.</given-names></name> <name><surname>Karas</surname> <given-names>P. J.</given-names></name> <name><surname>Krueger</surname> <given-names>D. A.</given-names></name> <name><surname>Weiner</surname> <given-names>H. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Central nervous system manifestations of tuberous sclerosis complex.</article-title> <source><italic>Am. J. Med. Genet. C Semin. Med. Genet.</italic></source> <volume>178</volume> <fpage>291</fpage>&#x2013;<lpage>298</lpage>.</citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantegazza</surname> <given-names>M.</given-names></name> <name><surname>Catterall</surname> <given-names>W. A.</given-names></name></person-group> (<year>2012</year>). <source><italic>Voltage-gated Na+ channels: Structure, function, and pathophysiology</italic></source>, <edition>4th Edn</edition>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information (US)</publisher-name>.</citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormack</surname> <given-names>K.</given-names></name> <name><surname>Mccormack</surname> <given-names>T.</given-names></name> <name><surname>Tanouye</surname> <given-names>M.</given-names></name> <name><surname>Rudy</surname> <given-names>B.</given-names></name> <name><surname>St&#x00FC;hmer</surname> <given-names>W.</given-names></name></person-group> (<year>1995</year>). <article-title>Alternative splicing of the human Shaker K+ channel beta 1 gene and functional expression of the beta 2 gene product.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>370</volume> <fpage>32</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(95)00785-8</pub-id> <pub-id pub-id-type="pmid">7649300</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname> <given-names>L. F. S.</given-names></name> <name><surname>Sabi&#x00E1; J&#x00FA;nior</surname> <given-names>E. F.</given-names></name> <name><surname>Tibery</surname> <given-names>D. V.</given-names></name> <name><surname>Carneiro</surname> <given-names>L. D. A.</given-names></name> <name><surname>Schwartz</surname> <given-names>E. F.</given-names></name></person-group> (<year>2020</year>). <article-title>Epilepsy-related voltage-gated sodium channelopathies: A review.</article-title> <source><italic>Front. Pharmacol.</italic></source> <volume>11</volume>:<issue>1276</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2020.01276</pub-id> <pub-id pub-id-type="pmid">33013363</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>X.-F.</given-names></name> <name><surname>Yu</surname> <given-names>J.-T.</given-names></name> <name><surname>Song</surname> <given-names>J.-H.</given-names></name> <name><surname>Chi</surname> <given-names>S.</given-names></name> <name><surname>Tan</surname> <given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of the mTOR signaling pathway in epilepsy.</article-title> <source><italic>J. Neurol. Sci.</italic></source> <volume>332</volume> <fpage>4</fpage>&#x2013;<lpage>15</lpage>.</citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>J. D.</given-names></name> <name><surname>Iyer</surname> <given-names>A. M.</given-names></name> <name><surname>Van Scheppingen</surname> <given-names>J.</given-names></name> <name><surname>Bongaarts</surname> <given-names>A.</given-names></name> <name><surname>Anink</surname> <given-names>J. J.</given-names></name> <name><surname>Janssen</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: Implications for pathophysiology and treatment.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>7</volume>:<issue>8089</issue>.</citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mochida</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Presynaptic calcium channels.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>20</volume>:<issue>2217</issue>.</citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>L. H.</given-names></name> <name><surname>Mahadeo</surname> <given-names>T.</given-names></name> <name><surname>Bordey</surname> <given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>39</volume> <fpage>2762</fpage>&#x2013;<lpage>2773</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2260-18.2019</pub-id> <pub-id pub-id-type="pmid">30700531</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niere</surname> <given-names>F.</given-names></name> <name><surname>Raab-Graham</surname> <given-names>K. F.</given-names></name></person-group> (<year>2017</year>). <article-title>mTORc1 is a local, postsynaptic voltage sensor regulated by positive and negative feedback pathways.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>11</volume>:<issue>152</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00152</pub-id> <pub-id pub-id-type="pmid">28611595</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niere</surname> <given-names>F.</given-names></name> <name><surname>Uneri</surname> <given-names>A.</given-names></name> <name><surname>Mcardle</surname> <given-names>C. J.</given-names></name> <name><surname>Deng</surname> <given-names>Z.</given-names></name> <name><surname>Egido-Betancourt</surname> <given-names>H. X.</given-names></name> <name><surname>Cacheaux</surname> <given-names>L. P.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in dendrites in tuberous sclerosis complex and Alzheimer&#x2019;s disease.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>120</volume>:<issue>e2301534120</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2301534120</pub-id> <pub-id pub-id-type="pmid">37903257</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Callaghan</surname> <given-names>F.</given-names></name> <name><surname>Harris</surname> <given-names>T.</given-names></name> <name><surname>Joinson</surname> <given-names>C.</given-names></name> <name><surname>Bolton</surname> <given-names>P.</given-names></name> <name><surname>Noakes</surname> <given-names>M.</given-names></name> <name><surname>Presdee</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex.</article-title> <source><italic>Arch. Dis. Child.</italic></source> <volume>89</volume> <fpage>530</fpage>&#x2013;<lpage>533</lpage>.</citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogiwara</surname> <given-names>I.</given-names></name> <name><surname>Miyamoto</surname> <given-names>H.</given-names></name> <name><surname>Morita</surname> <given-names>N.</given-names></name> <name><surname>Atapour</surname> <given-names>N.</given-names></name> <name><surname>Mazaki</surname> <given-names>E.</given-names></name> <name><surname>Inoue</surname> <given-names>I.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: A circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>27</volume>:<issue>5903</issue>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5270-06.2007</pub-id> <pub-id pub-id-type="pmid">17537961</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogiwara</surname> <given-names>I.</given-names></name> <name><surname>Miyamoto</surname> <given-names>H.</given-names></name> <name><surname>Tatsukawa</surname> <given-names>T.</given-names></name> <name><surname>Yamagata</surname> <given-names>T.</given-names></name> <name><surname>Nakayama</surname> <given-names>T.</given-names></name> <name><surname>Atapour</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice.</article-title> <source><italic>Commun. Biol.</italic></source> <volume>1</volume>:<issue>96</issue>. <pub-id pub-id-type="doi">10.1038/s42003-018-0099-2</pub-id> <pub-id pub-id-type="pmid">30175250</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellock</surname> <given-names>J. M.</given-names></name> <name><surname>Hrachovy</surname> <given-names>R.</given-names></name> <name><surname>Shinnar</surname> <given-names>S.</given-names></name> <name><surname>Baram</surname> <given-names>T. Z.</given-names></name> <name><surname>Bettis</surname> <given-names>D.</given-names></name> <name><surname>Dlugos</surname> <given-names>D. J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Infantile spasms: A U.S. consensus report.</article-title> <source><italic>Epilepsia</italic></source> <volume>51</volume> <fpage>2175</fpage>&#x2013;<lpage>2189</lpage>.</citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poolos</surname> <given-names>N. P.</given-names></name> <name><surname>Johnston</surname> <given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Dendritic ion channelopathy in acquired epilepsy.</article-title> <source><italic>Epilepsia</italic></source> <volume>53</volume> <fpage>32</fpage>&#x2013;<lpage>40</lpage>.</citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Punetha</surname> <given-names>J.</given-names></name> <name><surname>Karaca</surname> <given-names>E.</given-names></name> <name><surname>Gezdirici</surname> <given-names>A.</given-names></name> <name><surname>Lamont</surname> <given-names>R. E.</given-names></name> <name><surname>Pehlivan</surname> <given-names>D.</given-names></name> <name><surname>Marafi</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Biallelic Cacna2D2 variants in epileptic encephalopathy and cerebellar atrophy.</article-title> <source><italic>Ann. Clin. Transl. Neurol.</italic></source> <volume>6</volume> <fpage>1395</fpage>&#x2013;<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.50824</pub-id> <pub-id pub-id-type="pmid">31402629</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raab-Graham</surname> <given-names>K. F.</given-names></name> <name><surname>Niere</surname> <given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>mTOR referees memory and disease through mRNA repression and competition.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>591</volume> <fpage>1540</fpage>&#x2013;<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12675</pub-id> <pub-id pub-id-type="pmid">28493559</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raab-Graham</surname> <given-names>K. F.</given-names></name> <name><surname>Haddick</surname> <given-names>P. C. G.</given-names></name> <name><surname>Jan</surname> <given-names>Y. N.</given-names></name> <name><surname>Jan</surname> <given-names>L. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.</article-title> <source><italic>Science</italic></source> <volume>314</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.1126/science.1131693</pub-id> <pub-id pub-id-type="pmid">17023663</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radzicki</surname> <given-names>D.</given-names></name> <name><surname>Yau</surname> <given-names>H.-J.</given-names></name> <name><surname>Pollema-Mays</surname> <given-names>S. L.</given-names></name> <name><surname>Mlsna</surname> <given-names>L.</given-names></name> <name><surname>Cho</surname> <given-names>K.</given-names></name> <name><surname>Koh</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>33</volume> <fpage>9920</fpage>&#x2013;<lpage>9931</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5482-12.2013</pub-id> <pub-id pub-id-type="pmid">23761887</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajakulendran</surname> <given-names>S.</given-names></name> <name><surname>Hanna</surname> <given-names>M. G.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of calcium channels in epilepsy.</article-title> <source><italic>Cold Spring Harb. Perspect. Med.</italic></source> <volume>6</volume>:<issue>a022723</issue>.</citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randle</surname> <given-names>S. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Tuberous sclerosis complex: A review.</article-title> <source><italic>Pediatr. Ann.</italic></source> <volume>46</volume> <fpage>e166</fpage>&#x2013;<lpage>e171</lpage>.</citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname> <given-names>E. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Applying the lessons of tuberous sclerosis: The 2015 Hower award lecture.</article-title> <source><italic>Pediatr. Neurol.</italic></source> <volume>63</volume> <fpage>6</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2016.07.003</pub-id> <pub-id pub-id-type="pmid">27543366</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname> <given-names>C. A.</given-names></name> <name><surname>Tempel</surname> <given-names>B. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Kv1.1 and Kv1.2: Similar channels, different seizure models.</article-title> <source><italic>Epilepsia</italic></source> <volume>53</volume> <fpage>134</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03484.x</pub-id> <pub-id pub-id-type="pmid">22612818</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmunk</surname> <given-names>G.</given-names></name> <name><surname>Gargus</surname> <given-names>J. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Channelopathy pathogenesis in autism spectrum disorders.</article-title> <source><italic>Front. Genet.</italic></source> <volume>4</volume>:<issue>222</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2013.00222</pub-id> <pub-id pub-id-type="pmid">24204377</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ser&#x00F4;dio</surname> <given-names>P.</given-names></name> <name><surname>Rudy</surname> <given-names>B.</given-names></name></person-group> (<year>1998</year>). <article-title>Differential expression of Kv4 K+ channel subunits mediating subthreshold transient K+ (A-Type) currents in rat brain.</article-title> <source><italic>J. Neurophysiol.</italic></source> <volume>79</volume> <fpage>1081</fpage>&#x2013;<lpage>1091</lpage>.</citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siddaraju</surname> <given-names>M. L. S.</given-names></name> <name><surname>Reddy</surname> <given-names>T.</given-names></name> <name><surname>Bandari</surname> <given-names>A. K.</given-names></name></person-group> (<year>2016</year>). <article-title>A case of tuberous sclerosis - presenting as febrile seizures with status epilepticus.</article-title> <source><italic>Int. J. Contemp. Pediatr.</italic></source> <volume>3</volume>:<issue>4</issue>.</citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname> <given-names>B. A.</given-names></name> <name><surname>Zamponi</surname> <given-names>G. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuronal voltage-gated calcium channels: Structure, function, and dysfunction.</article-title> <source><italic>Neuron</italic></source> <volume>82</volume> <fpage>24</fpage>&#x2013;<lpage>45</lpage>.</citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smets</surname> <given-names>K.</given-names></name> <name><surname>Duarri</surname> <given-names>A.</given-names></name> <name><surname>Deconinck</surname> <given-names>T.</given-names></name> <name><surname>Ceulemans</surname> <given-names>B.</given-names></name> <name><surname>Van De Warrenburg</surname> <given-names>B. P.</given-names></name> <name><surname>Z&#x00FC;chner</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>First de novo Kcnd3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.</article-title> <source><italic>BMC Med. Genet.</italic></source> <volume>16</volume>:<issue>51</issue>. <pub-id pub-id-type="doi">10.1186/s12881-015-0200-3</pub-id> <pub-id pub-id-type="pmid">26189493</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sosanya</surname> <given-names>N. M.</given-names></name> <name><surname>Brager</surname> <given-names>D. H.</given-names></name> <name><surname>Wolfe</surname> <given-names>S.</given-names></name> <name><surname>Niere</surname> <given-names>F.</given-names></name> <name><surname>Raab-Graham</surname> <given-names>K. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Rapamycin reveals an mtor-independent repression of Kv1.1 expression during epileptogenesis.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>73</volume> <fpage>96</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.09.011</pub-id> <pub-id pub-id-type="pmid">25270294</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sosanya</surname> <given-names>N. M.</given-names></name> <name><surname>Huang</surname> <given-names>P. P. C.</given-names></name> <name><surname>Cacheaux</surname> <given-names>L. P.</given-names></name> <name><surname>Chen</surname> <given-names>C. J.</given-names></name> <name><surname>Nguyen</surname> <given-names>K.</given-names></name> <name><surname>Perrone-Bizzozero</surname> <given-names>N. I.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mtorc1.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>202</volume> <fpage>53</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201212089</pub-id> <pub-id pub-id-type="pmid">23836929</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stafstrom</surname> <given-names>C. E.</given-names></name> <name><surname>Carmant</surname> <given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Seizures and epilepsy: An overview for neuroscientists.</article-title> <source><italic>Cold Spring Harb. Perspect. Med.</italic></source> <volume>5</volume>:<issue>a022426</issue>.</citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stafstrom</surname> <given-names>C. E.</given-names></name> <name><surname>Staedtke</surname> <given-names>V.</given-names></name> <name><surname>Comi</surname> <given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Epilepsy mechanisms in neurocutaneous disorders: Tuberous sclerosis complex, neurofibromatosis type 1, and Sturge&#x2013;Weber syndrome.</article-title> <source><italic>Front. Neurol.</italic></source> <volume>8</volume>:<issue>87</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00087</pub-id> <pub-id pub-id-type="pmid">28367137</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Switon</surname> <given-names>K.</given-names></name> <name><surname>Kotulska</surname> <given-names>K.</given-names></name> <name><surname>Janusz-Kaminska</surname> <given-names>A.</given-names></name> <name><surname>Zmorzynska</surname> <given-names>J.</given-names></name> <name><surname>Jaworski</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular neurobiology of mTOR.</article-title> <source><italic>Neuroscience</italic></source> <volume>341</volume> <fpage>112</fpage>&#x2013;<lpage>153</lpage>.</citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnol</surname> <given-names>A.</given-names></name> <name><surname>Traor&#x00E9;</surname> <given-names>M.</given-names></name> <name><surname>Pietri-Rouxel</surname> <given-names>F.</given-names></name> <name><surname>Falcone</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>New insights in CaV&#x03B2; subunits: Role in the regulation of gene expression and cellular homeostasis.</article-title> <source><italic>Front. Cell. Dev. Biol.</italic></source> <volume>10</volume>:<issue>880441</issue>. <pub-id pub-id-type="doi">10.3389/fcell.2022.880441</pub-id> <pub-id pub-id-type="pmid">35465309</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname> <given-names>C.</given-names></name> <name><surname>Combi</surname> <given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Potassium channels and human epileptic phenotypes: An updated overview.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>10</volume>:<issue>81</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00081</pub-id> <pub-id pub-id-type="pmid">27064559</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Kunkel</surname> <given-names>D. D.</given-names></name> <name><surname>Martin</surname> <given-names>T. M.</given-names></name> <name><surname>Schwartzkroin</surname> <given-names>P. A.</given-names></name> <name><surname>Tempel</surname> <given-names>B. L.</given-names></name></person-group> (<year>1993</year>). <article-title>Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons.</article-title> <source><italic>Nature</italic></source> <volume>365</volume> <fpage>75</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1038/365075a0</pub-id> <pub-id pub-id-type="pmid">8361541</pub-id></citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>Z.-J.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>H.-Q.</given-names></name> <name><surname>Shi</surname> <given-names>Y.-W.</given-names></name> <name><surname>Yi</surname> <given-names>Y.-H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Epilepsy-associated genes</article-title>. <source><italic>Seizure</italic></source> <volume>44</volume>, <fpage>11</fpage>&#x2013;<lpage>20</lpage>.</citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Xue</surname> <given-names>L.</given-names></name> <name><surname>Xing</surname> <given-names>J.</given-names></name> <name><surname>Jouvin</surname> <given-names>M. H.</given-names></name> <name><surname>Putney</surname> <given-names>J. W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Low-voltage-activated CaV3.1 calcium channels shape T helper cell cytokine profiles.</article-title> <source><italic>Immunity</italic></source> <volume>44</volume> <fpage>782</fpage>&#x2013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.015</pub-id> <pub-id pub-id-type="pmid">27037192</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wappl</surname> <given-names>E.</given-names></name> <name><surname>Koschak</surname> <given-names>A.</given-names></name> <name><surname>Poteser</surname> <given-names>M.</given-names></name> <name><surname>Sinnegger</surname> <given-names>M. J.</given-names></name> <name><surname>Walter</surname> <given-names>D.</given-names></name> <name><surname>Eberhart</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Functional consequences of P/Q-type Ca2+channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>277</volume> <fpage>6960</fpage>&#x2013;<lpage>6966</lpage>.</citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weissgerber</surname> <given-names>P.</given-names></name> <name><surname>Held</surname> <given-names>B.</given-names></name> <name><surname>Bloch</surname> <given-names>W.</given-names></name> <name><surname>Kaestner</surname> <given-names>L.</given-names></name> <name><surname>Chien</surname> <given-names>K. R.</given-names></name> <name><surname>Fleischmann</surname> <given-names>B. K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Reduced cardiac L-type Ca2+ current in Ca(V)beta2-/- embryos impairs cardiac development and contraction with secondary defects in vascular maturation.</article-title> <source><italic>Circ. Res.</italic></source> <volume>99</volume> <fpage>749</fpage>&#x2013;<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000243978.15182.c1</pub-id> <pub-id pub-id-type="pmid">16946137</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolff</surname> <given-names>M.</given-names></name> <name><surname>Johannesen</surname> <given-names>K. M.</given-names></name> <name><surname>Hedrich</surname> <given-names>U. B. S.</given-names></name> <name><surname>Masnada</surname> <given-names>S.</given-names></name> <name><surname>Rubboli</surname> <given-names>G.</given-names></name> <name><surname>Gardella</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders</article-title>. <source><italic>Brain</italic></source> <volume>140</volume>, <fpage>1316</fpage>&#x2013;<lpage>1336</lpage>.</citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.</article-title> <source><italic>Epilepsia</italic></source> <volume>49</volume> <fpage>8</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01270.x</pub-id> <pub-id pub-id-type="pmid">17727667</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>A critical review of mTOR inhibitors and epilepsy: From basic science to clinical trials.</article-title> <source><italic>Expert Rev. Neurother.</italic></source> <volume>13</volume> <pub-id pub-id-type="doi">10.1586/ern.13.48</pub-id> <pub-id pub-id-type="pmid">23739003</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wormuth</surname> <given-names>C.</given-names></name> <name><surname>Lundt</surname> <given-names>A.</given-names></name> <name><surname>Henseler</surname> <given-names>C.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>R.</given-names></name> <name><surname>Broich</surname> <given-names>K.</given-names></name> <name><surname>Papazoglou</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Review: Ca(v)2.3 R-type voltage-gated Ca(2+) channels - functional implications in convulsive and non-convulsive seizure activity.</article-title> <source><italic>Open Neurol. J.</italic></source> <volume>10</volume> <fpage>99</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.2174/1874205X01610010099</pub-id> <pub-id pub-id-type="pmid">27843503</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>C.</given-names></name> <name><surname>Su</surname> <given-names>H.</given-names></name> <name><surname>Guo</surname> <given-names>T.</given-names></name> <name><surname>Yan</surname> <given-names>Y.</given-names></name> <name><surname>Peng</surname> <given-names>X.</given-names></name> <name><surname>Cao</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Synaptotagmin I delays the fast inactivation of Kv1.4 channel through interaction with its N-terminus.</article-title> <source><italic>Mol. Brain</italic></source> <volume>7</volume>:<issue>4</issue>. <pub-id pub-id-type="doi">10.1186/1756-6606-7-4</pub-id> <pub-id pub-id-type="pmid">24423395</pub-id></citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>C.</given-names></name> <name><surname>Hua</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Gao</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Variable epilepsy phenotypes associated with heterozygous mutation in the SCN9A gene: Report of two cases</article-title>. <source><italic>Neurol. Sci</italic></source>. <volume>39</volume>, <fpage>1113</fpage>&#x2013;<lpage>1115</lpage>.</citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>F. H.</given-names></name> <name><surname>Catterall</surname> <given-names>W. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Overview of the voltage-gated sodium channel family.</article-title> <source><italic>Genome Biol.</italic></source> <volume>4</volume> <fpage>207</fpage>&#x2013;<lpage>207</lpage>.</citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yum</surname> <given-names>M.-S.</given-names></name> <name><surname>Lee</surname> <given-names>E. H.</given-names></name> <name><surname>Ko</surname> <given-names>T.-S.</given-names></name></person-group> (<year>2013</year>). <article-title>Vigabatrin and mental retardation in tuberous sclerosis: Infantile spasms versus focal seizures.</article-title> <source><italic>J. Child Neurol.</italic></source> <volume>28</volume> <fpage>308</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1177/0883073812446485</pub-id> <pub-id pub-id-type="pmid">22752486</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname> <given-names>T.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Park</surname> <given-names>C.</given-names></name> <name><surname>Paydar</surname> <given-names>A.</given-names></name> <name><surname>Choi</surname> <given-names>J. H.</given-names></name> <name><surname>Cheong</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Cav2.3 channels are critical for oscillatory burst discharges in the reticular thalamus and absence epilepsy.</article-title> <source><italic>Neuron</italic></source> <volume>70</volume> <fpage>95</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.042</pub-id> <pub-id pub-id-type="pmid">21482359</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamponi</surname> <given-names>G. W.</given-names></name> <name><surname>Striessnig</surname> <given-names>J.</given-names></name> <name><surname>Koschak</surname> <given-names>A.</given-names></name> <name><surname>Dolphin</surname> <given-names>A. C.</given-names></name></person-group> (<year>2015</year>). <article-title>The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential.</article-title> <source><italic>Pharmacol. Rev.</italic></source> <volume>67</volume> <fpage>821</fpage>&#x2013;<lpage>870</lpage>.</citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zemel</surname> <given-names>B. M.</given-names></name> <name><surname>Ritter</surname> <given-names>D. M.</given-names></name> <name><surname>Covarrubias</surname> <given-names>M.</given-names></name> <name><surname>Muqeem</surname> <given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>A-type K(V) channels in dorsal root ganglion neurons: Diversity, function, and dysfunction.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>11</volume>:<issue>253</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00253</pub-id> <pub-id pub-id-type="pmid">30127716</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>L. H.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Gutmann</surname> <given-names>D. H.</given-names></name> <name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>63</volume> <fpage>444</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21331</pub-id> <pub-id pub-id-type="pmid">18389497</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>L.-H.</given-names></name> <name><surname>Rensing</surname> <given-names>N. R.</given-names></name> <name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>The mammalian target of Rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>29</volume> <fpage>6964</fpage>&#x2013;<lpage>6972</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0066-09.2009</pub-id> <pub-id pub-id-type="pmid">19474323</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T.</given-names></name> <name><surname>Chen</surname> <given-names>M.</given-names></name> <name><surname>Zhu</surname> <given-names>A.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Fang</surname> <given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Novel mutation of SCN9A gene causing generalized epilepsy with febrile seizures plus in a Chinese family.</article-title> <source><italic>Neurol. Sci.</italic></source> <volume>41</volume> <fpage>1913</fpage>&#x2013;<lpage>1917</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-020-04284-x</pub-id> <pub-id pub-id-type="pmid">32062735</pub-id></citation></ref>
<ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Kong</surname> <given-names>W.</given-names></name> <name><surname>Gao</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Gao</surname> <given-names>K.</given-names></name> <name><surname>Xie</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Gene mutation analysis in 253 chinese children with unexplained epilepsy and intellectual/developmental disabilities.</article-title> <source><italic>PLoS One</italic></source> <volume>10</volume>:<issue>e0141782</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0141782</pub-id> <pub-id pub-id-type="pmid">26544041</pub-id></citation></ref>
<ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Gutmann David</surname> <given-names>H.</given-names></name> <name><surname>Wong</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.</article-title> <source><italic>Epilepsia</italic></source> <volume>58</volume> <fpage>2053</fpage>&#x2013;<lpage>2063</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13923</pub-id> <pub-id pub-id-type="pmid">29023667</pub-id></citation></ref>
</ref-list>
</back>
</article>